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Previous work in our laboratory has demonstrated not only a synthetic value of 
tandem reductive cyclization – carbonylation reactions in the preparation of complex 
molecules but also the interesting stereoselectivity observed therein. 
The first part of this work employs the titanium-mediated cyclocarbonylation of 
tethered dienals for the synthesis of prostaglandin analogues, in particular PGF2α and 
methyl jasmonate. Based on this hetero Pauson-Khand strategy, we have established an 
efficient racemic route to both the prostaglandin and the methyl jasmonate core skeletons. 
Moderate to excellent selectivities with regard to the hetero Pauson-Khand reaction were 
observed in both cases.  
The second part of our study leads towards the novel synthesis of the biologically 
active α-methylene-γ-butyrolactone moiety via titanium mediated hetero Pauson-Khand 
reaction of allenic aldehyde/ketone substrates. This substructure is embodied in many 
natural products such as Sarkomycin and Frullanolide which have excellent antibacterial 
and anticancer activities.   
The final part of this study describes the development of the titanium-mediated 
reductive cyclocarbonylation and an imino-alkyne cross-metathesis strategy towards the 
synthesis of pyrrolizidine and indolizidine alkaloids respectively. The same substrates 




AN OVERVIEW OF THE HETERO PAUSON-KHAND REACTION 
 
1.1 Introduction to the Pauson-Khand Reaction 
 Metal mediated and catalyzed reactions have made significant contributions to 
organic synthesis over the past decades. The growing interest in the development of 
organic reactions mediated and catalyzed by organotransition metals stems from the 
ability to assemble complex molecules from simple starting materials in a convergent and 
atom-economical manner.1.1 An important area of investigation toward this end has 
involved metal-mediated and -catalyzed cycloaddition reactions between carbonyl and 
unsaturated bonds as a means to find a practical way for the construction of cyclic 
frameworks. The Pauson-Khand reaction1.2 is one such intriguing reaction that 
exemplifies this concept. It is a three-component formal metal-mediated (or catalyzed) 
[2 + 2 + 1]-cycloaddition of an alkyne π-bond, an alkene π-bond, and carbon monoxide 













[2 + 2 + 1]
 
Scheme 1.1 Pauson-Khand Reaction 
The Pauson-Khand reaction was first discovered in 1971,1.3 and at that time, this 
cycloaddition process was accomplished with high temperatures using a stoichiometric 
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amount of dicobalt octacarbonyl (Co2CO8). The generation of the moderately air stable 
Co-acetylene complexes is the key property of this reagent. These complexes are formed 
at ambient temperature by stirring solutions of Co2(CO)8 and the alkyne. The Pauson-
Khand reaction has seen a remarkable growth in popularity and has become nowadays 
one of the most convergent and versatile methods for the synthesis of cyclopentenones. 
The Pauson-Khand reaction is compatible with a wide variety of functionalities such as 
alcohols, ethers, esters, tertiary amines and amides, nitriles, aromatic and hetero-aromatic 
rings. Initially, the scope of the reaction was limited to the use of strained olefins with the 
exception of ethylene itself. Harsh conditions were employed to effect the transformation 
and this sometimes led to the decomposition of starting materials and products. Also, 
regioselectivity was a problem. 
1.2 Intramolecular Pauson-Khand Reaction 
In the early eighties, Shore and co-workers demonstrated the considerable 
synthetic utility of this reaction by attaching the alkene to the alkyne via a carbon tether 
and introduced the first intramolecular version of the Pauson-Khand reaction (Scheme 
1.2).1.4 As defined earlier, the intermolecular variant involves the reaction of three 
separate compounds: an alkyne, an alkene and CO. The intramolecular variant however, 
involves the reaction of an enyne and CO. Though tremendous attention has been devoted 
to the intermolecular reaction, much of the interest in the area today is due to the 





Scheme 1.2 First Intramolecular Pauson-Khand Reaction 
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1.3 Promoters 
As mentioned before, with the early intermolecular variants of the Pauson-Khand 
reactions, regioselectivity was a problem and strained olefins were necessay for the 
efficient conversion from starting materials to products. Now, with the establishment of 
the intramolecular Pauson-Khand reaction, strained alkenes are no longer necessary and 
regioselectivity is not a problem. With this discovery, came other improvements on the 
optimization of the reaction conditions. In the early nineties, Schreiber1.5 and Jeong1.6 
independently reported the promotion of the Pauson-Khand reaction using tertiary amine 
N-oxides that generate free coordination sites at the cobalt metal center by oxidative 
removal of CO ligands. These promoters have since helped to circumvent the need for 
high temperatures and long reaction times and have allowed for a significant acceleration 
of the Pauson-Khand reaction at room temperature and in high yields (Scheme 1.3). 
Other promoters such as silica gel,1.7 dimethyl sulfoxide (DMSO)1.8 and molecular 
sieves1.9 have also been reported but tertiary amine N-oxides like N-methyl morphorline-
N-oxide (NMO)1.10 and trimethyl amine-N-oxide (TMANO)1.11 are still the most widely 
employed. 
 
Scheme 1.3 Utilizing Tertiary N-Oxides 
1.4 Mechanism of the Pauson-Khand Reaction 
 Beyond the fact that a hexacarbonyldicobalt-alkyne complex is involved, little is 
actually known about the mechanism of the Pauson-Khand reaction. The current level of 
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mechanistic understanding is inferred from observations of regio- and stereochemistry in 
a large number of examples. A working and widely accepted mechanistic pathway was 

































































Scheme 1.4 Proposed Mechanism of the Pauson-Khand Reaction 
The first step in the mechanistic sequence would be alkyne complexation, followed by 
dissociation of a CO ligand and coordination of the alkene. This ligand substitution step 
is presumably the rate-determining step while the following step, cobaltacycle formation, 
is the product-determining step, since (with adequately substituted substrates) it 
determines both the regiochemistry and the stereochemistry of the product 
cyclopentenone. Finally, the cobaltacycle that forms then proceeds to the final product by 
a standard sequence of steps beginning with CO insertion, reductive elimination and loss 
of the cobalt moiety or decomplexation. 
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1.5 Cobalt Catalyzed Pauson-Khand Reaction  
In order to fulfill the criterion of atom economy,1.1 there has been a surge in the 
development of the catalytic version of the Pauson-Khand reaction. Ever since Pauson 
and co-workers reported in 1973, 1.11 the first catalytic Co2(CO)8 cycloaddition, (0.023 
equiv.) utilizing norbornene under one atmosphere of a 1:1 mixture of acetylene and CO 
in DME at 60-70 oC to provide a 62% yield of the cyclopentenone, there has been a 
growth in the utility of the original catalyst.  
In 1990, Rautenstrauch and co-workers1.12 reported the synthesis of the di-
hydrojasmonate precursor 1.0a from ethylene and hept-1-yne. However, the major 
drawback of this protocol was the use of high pressures of CO (100 atm) and a 











Scheme 1.5 Rautenstrauch’s Catalytic Intermolecular Pauson-Khand Reaction 
The situation changed at the end of the decade, when a practical catalytic 
procedure involving photoactivation of Co2(CO)8 under low CO pressures (Scheme 1.6) 
was published by Livinghouse.1.13 Krafft and co-workers,1.14 also reported high yielding 
catalytic Pauson-Khand reactions by using only 1 atm of CO. However, where 
Livinghouse put great emphasis on the use of highly pure catalysts, Krafft went further to 
enhance the efficiency of the reaction by addition of Lewis bases such as 
cyclohexylamine which act by stabilizing the reaction intermediates. 
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Scheme 1.6 Livinghouse’s and Krafft’s Intramolecular Pauson-Khand Reaction 
Other compounds have been employed as additives to aid in the acceleration of the 
catalytic Pauson-Khand reaction. In 1994, Jeong and co-workers1.15 subsequently reported 
the addition of phosphines, phosphites and chiral phosphites such as (S)-BINAP in their 






80 oC 1 atm CO
Yield: 54%
ee%: 94%  
Scheme 1.7 Jeong’s Catalytic Pauson-Khand Reaction with (S)-BINAP 
1.6 Other Transition Metal Catalysts 
In recent years, other transition metal complexes besides Co2(CO)8 have been 
used to catalyze/mediate the Pauson-Khand reaction. These various transition metal-
complexes include molybdenium,1.16 zirconium,1.17 rhodium,1.18 iron,1.19 ruthenium,1.20 
and titanium.1.21 Not only do some of these metal-complexes exhibit impressive catalytic 
ability, but based on their intrinsic design, asymmetric variants of the catalytic 
cycloaddition are now available.            
Beginning with molybdenium metal, Jeong1.22 has reported that the cycloaddition 











Scheme 1.8 Jeong’s Mo-Mediated Pauson-Khand Reaction 
Negishi and co-workers1.17 have reported the zirconium metal-mediated Pauson-
Khand reaction which directs the conversion of enynes into the corresponding 
metallacycles, followed by conversion into enones (Scheme 1.9). 
 
Scheme 1.9 Negishi’s Zr-Mediated Pauson-Khand Reaction 
 Chloro-bridged rhodium dimers such as the ones established by Narasaka1.23 
(Scheme 1.10) and Jeong1.18 have been shown to promote the catalytic cycloaddition 
process. In 1998, these two groups simultaneously published reports that showed that, 
rhodium-based catalysts could be used to effect these transformations under one 
atmosphere of CO. 
 
Scheme 1.10 Narasaka’s Rh-Catalyzed Pauson-Khand Reaction 
In 1994, Pearson and Dubbert reported the iron carbonyl promoted Pauson-Khand 
reaction (Scheme 1.11).1.19 The reaction with iron carbonyl is not catalytic and the iron 
carbonyl is actually used in excess. The efficiency of the reaction is improved when, in 
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place of Fe(CO)5, a pre-made complex such as Fe(CO)4(solvent) is used instead. Despite 
the form of the catalyst, high temperatures must be maintained regardless. 
 
Scheme 1.11 Fe-Mediated Pauson-Khand Reaction 
The scope of ruthenium carbonyl catalyzed reactions spans wide over a number of 
carbon-carbon bond forming reactions including the Pauson-Khand reaction. The first 
examples of the ruthenium-catalyzed Pauson-Khand reactions employing Ru3(CO)12 as 
the catalyst was discovered simultaneously by Mitsudo1.24 and Murai1.20 in 1997. These 
early reactions required high temperatures of about 140 oC to 180 oC and about 10-15 atm 
CO pressure (Scheme 1.12). 
 
Scheme 1.12 Murai’s Ru-Catalyzed Intramolecular Pauson-Khand Reaction 
 In 1993, Buchwald and co-workers reported a titanium-based method for 
cyclopentenone synthesis (Scheme 1.13).1.21  
Cp2Ti(PMe3)2 (10 mol%)
PhMe
R3SiCN, 45 oC, 18-24 h
R = Me, Ph, n-Bu










Scheme 1.13 Buchwald’s Ti-Catalyzed Pauson-Khand Reaction with Isonitriles 
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This reaction proceeds as follows; the initial intermediate titanacyclopentene formed is 
captured by isocyanides and the resulting intermediate iminocyclopentene is 
subsequently hydrolyzed to the cyclopentenone. They have also been successful at 
avoiding the use of the air- and moisture-sensitive Cp2Ti(PMe3)2 by utilizing a catalyst 
which is generated in situ from another titanocene, Cp2TiCl2. 
1.7 γ-Butyrolactone Synthesis via the Hetero Pauson-Khand Reaction 
 In 1996, Dr. Crowe’s laboratory and others, were the first to report the 
Cp2Ti(PMe3)2 mediated [2 + 2 + 1] cycloaddition of δ-unsaturated ketones and aldehydes 
with carbon monoxide into bicyclic γ-butyrolactones and coined the phrase “hetero 
Pauson-Khand reaction” (Scheme 1.14).1.25   
 
Scheme 1.14 Hetero Pauson-Khand Reaction 
These reactions can be performed under mild conditions (low temperature and CO 
pressure) and high yield. The hetero Pauson-Khand reaction involves three key 
sequences. The first is the reductive coupling step of the pair of unsaturated organic 
fragments with the transition metal center to form a metallacycle. This is followed by 
carbonylation, which is the insertion of one equivalent of carbon monoxide into the Ti-C 
bond of the metallacycle, thus forming the carbonylated metallacycle. The final step, 
reductive elimination, is the loss of the titanium metal with ligands and leads to the 
formation of the cis-fused γ-butyrolactone. Reductive elimination can be induced 
thermally or by facile exposure to air. The mechanism of the hetero Pauson-Khand 
reaction as just described is shown in Scheme 1.15. 
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Scheme 1.15 Mechanism of the Hetero Pauson-Khand Reaction 
1.8 Catalytic Hetero Pauson-Khand Reaction 
 Soon after our first discovery of the general type hetero Pauson-Khand reactions, 
Buchwald reported a catalytic version of the reaction using Cp2Ti(PMe3)2 or Cp2Ti(CO)2 
to convert conjugated aromatic ketones to the corresponding γ-butyrolactones.1.26 
However, this methodology had limited scope, since in general, the substrates feature 
only a keto moiety with an allyl group situated in an ortho-relationship on the aromatic 
ring (Scheme 1.16). 
 
Scheme 1.16 Buchwald’s Ti-Catalyzed Hetero Pauson-Khand Reaction 
Our group has recently published an asymmetric version of the hetero Pauson-
Khand reaction.1.27 This asymmetric hetero Pauson-Khand cyclization involves the air 
stable chiral ansa-metallocene catalyst, (EBTHI)Ti(CO)2, and enals or enones as the 
viable substrates (Scheme 1.17). The greater reactivity of (EBTHI)Ti(CO)2, over the 
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50 psig CO, toluene
36-40 h, 100 oC
(73-92%)
(EBTHI)Ti(CO)2
R = H or alkyl group
 
Scheme 1.17 Crowe’s Catalytic Asymmetric Cyclocarbonylation 
1.9 Ruthenium-Catalyzed Hetero Pauson-Khand Reaction 
Murai and co-workers pioneered the first catalytic hetero Pauson-Khand reaction 
of substrates such as ketones and aldehydes in place of either an alkyne or an alkene. 
Below in Scheme 1.18, is an example of the an intramolecular [2+2+1] cycloaddition of 
yne-aldehydes with CO to give unsaturated γ-butenolides.1.28 
 
Scheme 1.18 Ru-Catalyzed Intramolecular Hetero Pauson-Khand Reaction 
 
Scheme 1.19 Murai’s Ru-Catalyzed Intermolecular Cyclization 
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They also reported the intermolecular catalytic version of the hetero Pauson-
Khand cyclization of ketones or aldehydes, ethylene, and CO in the presence of 
Ru3(CO)12 (Scheme 1.19).1.29  
1.10 Research Overview 
 The Pauson-Khand cycloaddition has been successfully used as a key step in the 
synthesis of biologically relevant natural products1.30 and its high value will continue to 
be demonstrated in the formation of complex compounds from our laboratory and others. 
This introductory chapter, chapter 1, presents a brief summary and overview of the 
versatility of the hetero Pauson-Khand reaction. Chapter 2 demonstrates the utility of the 
hetero Pauson-Khand reaction as a synthetic approach towards the construction of 
intermediates relevant to the synthesis of prostaglandins and methyl jasmonate. Chapter 3 
presents the titanium-mediated hetero Pauson-Khand methodology for the preparation of 
α-methylene-γ-butyrolactones from allenic carbonyl substrates. Finally, chapter 4 
discusses an approach to the formation of the pyrrolizidine and indolizidine alkaloid 
skeletons via titanium-mediated synthesis.  
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APPLICATIONS OF THE HETERO PAUSON-KHAND REACTION: 
CONSTRUCTION OF COMPOUNDS RELEVANT TO THE SYNTHESES OF  
PROSTAGLANDINS AND METHYL JASMONATE 
 
2.1 An Introduction to Prostaglandins (PG’s) 
 Prostaglandins are very important naturally-occurring physiologically potent 
substances which have been the subject of continuous attention by biologist, pharmacists 
and chemists since their discovery in the 1930s by the Swedish physiologist Ulf von 
Euler.2.1 The chemical structures of prostaglandins are based on the structure of 
prostanoic acid which comprises of a five-membered carbon ring with two side chains. 
The classification of prostaglandins into groups and subgroups depends on unsaturation 
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Divided into series A, B, C, D and F
Numerical subscripts represent different pairs of side chains
 
Scheme 2.1 Prostaglandin Nomenclature 
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The side chain with the acid functionality is called the α side chain and the other the ω 
side chain. Depending on the different substitution patterns of the five membered ring, 
alphabetical designations are made (A, B, C,…) and the different numerical subscripts 
represent the different pairs of side chains. The structure of PGF2α is indicated by the 
highlighted structural elements in Scheme 2.1. Prostaglandins belong to the family of 
eicosanoids. The in vivo synthesis of eicosanoids starts from arachidonic acid, a 20 
carbon unsaturated fatty acid, which is converted in the presence of oxygen by two 
cyclooxygenase enzyme systems widely distributed in mammalian tissue to 
endoperoxides.2.2 These intermediates are isomerized or reduced by various enzymes to 
several types of eicosanoids (Scheme 2.2).2.3-4 Other members of the eicosanoids are the 
prostacyclins and the thromboxanes. 

































Scheme 2.2 Biosynthesis of Prostaglandins 
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All these eicosanoids play important regulatory roles in many normal cellular 
functions. They are found in the phospholipids of cell membranes. In contrast to 
hormones, they do not circulate nor are they stored in tissues. Rather they are synthesized 
locally on demand, perform a tissue-specific function and are rapidly inactivated by 
metabolic enzymes afterwards.  
Pharmacological studies have shown that prostaglandins in particular, exhibit an 
extremely broad spectrum of activity and have a great impact, depending on the type and 
tissue. Prostaglandins can stimulate smooth-muscle contraction, affect the cardiovascular 
system (lower or raise blood pressure), the nervous system (increase body temperature), 
the reproductive system (fertility), stimulate inflammation and cause a general increase of 
hormone secretion.2.5 
Three major problems associated with the use of natural prostaglandins as drugs 
have been encountered: (1) chemical instability, (2) rapid metabolism, and (3) incidence 
of numerous side effects. These problems have created a need to synthesize prostaglandin 
analogs without such limitations. A large number of analogs have been synthesized 
during the last couple of decades and many of these are being marketed today. They are 
used as antihypertensive, antiulcer and antiglaucoma drugs and play an important role in 
the field of fertility control.2.6 
 From the academic point of view, eicosanoids are still one of the most intensively 
studied class of natural products and every year hundreds of papers are published about 
these compounds in chemical, medicinal and biological journals like for example, 
Advances in Prostaglandin, Thromboxane and Leukotriene Research, and Prostaglandins 
& other Lipid Mediators.2.4 
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2.2 Synthesis of Prostaglandins 
 The first main contributions in this field are those from E. J. Corey. In the late 
1960s, Corey published a general route for the synthesis of several prostaglandins.2.7 This 
method has been extensively used in the synthesis of natural prostaglandins as well as 
many prostaglandins analogs. Also, although many precursors have been used for the 
synthesis of prostaglandins, Corey’s lactone, (Scheme 2.3) is one of the most successful 







Figure 2.1 Corey’s Lactone 
In the classical approach, side chains 4 and 2 were introduced by the Wittig and Wittig-





























Scheme 2.3 Corey’s Retrosynthetic Synthesis of PGF2α 
A second very powerful synthesis of prostaglandin analogs is based on the two 
component coupling.2.11 The key step is a conjugate addition reaction of an in situ formed 
cuprate from 5 to substituted enone 6 (Scheme 2.5). The optically pure precursor (R)-6 
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Scheme 2.4 Two Component Coupling 
Related is the three component coupling method developed by Noyori,2.13 which is one of 
the most elegant approaches because of the shortness of this convergent synthetic route. 
The key step of this method is the conjugate addition-aldol reaction connecting both side-















Scheme 2.5 Three Component Coupling 
2.3 Research Interests  
 Major areas of interest in Dr. Crowe’s group at the present time include medicinal 
chemistry, synthetic organic/organometallic chemistry, and natural products chemistry. 
More specifically, we are interested in the synthesis of natural products with biological 
activity or related analogs with enhanced activity. Research of this type has led us into 
the alkaloid, γ-butyrolactone, and α-methylene-γ-butyrolactone fields just to name a few. 
A central focal point that encompasses much of our research efforts is exploring the 
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scope of titanium mediated/catalyzed carbon-carbon bond-forming reactions. Metals of 
certain designs from across the periodic table may catalyze many C-C bond-forming 
reactions. However, titanium complexes have several advantages. First, titanium is the 
2nd most abundant transition element in the earth’s crust (after iron) and is quite 
inexpensive relative to many of the later metals, e.g. palladium. Consequently, 
catalyst/reagent loadings are much less a concern. Second, titanium is readily removed 
from products by flushing through an alumina or silica plug. And as a final point, on 
hydrolysis the metal containing product is TiO2, a nontoxic compound found in many of 
the foods we buy and in toothpastes.  In 1996, our laboratory provided the first examples 
of an intramolecular, titanium mediated hetero Pauson-Khand reaction of tethered enals 
2a-h.2.14 This strategy has subsequently been developed as a generally useful synthetic 
method. The three component [2 + 2 + 1] cycloaddition which incorporates the ketone or 
the aldehyde π-bond, the alkene π-bond, and the carbon atom of CO into the five-













25 oC, 12 h
air (1 atm)
Ether
25 oC, 4 h
2a-h 2'a-h 2''a-h 2'''a-h  
Scheme 2.6 Scope of the Hetero Pauson-Khand Reaction Outlined 
The mechanistic scheme of this reaction is exposure of titanium metallacycles 2'a-h, 
obtained by the reaction of a stiochiometric amount of Cp2Ti(PMe3)2 with olefinic 
aldehydes or ketones 2a-h, with CO followed by an oxidatively induced reductive  
elimination to give γ-butyrolactones 2'''a-h (Scheme 2.7). All metallacycles and γ 
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-butyrolactone products possess a cis-fused ring junction. Below in Table 2.1 are some 
previously reported substrates 2a-h which underwent tandem reductive cylization-
carbonylation reactions. Diasteroselectivity ratios of product metallacycles and γ-
butyrolactones are provided for substrates 2c, 2e, and 2f.  
Table 2.1 Previously Reported Substrates  
 Substrates 
2a-h
2a                                             91                   83                60
2b                                             84                   44                65
2ca                                           95                   64                57
2ea                                           89                   63                64
O
(a) Diastereoselectivity values provided below yields 
(b) A reasonably pure product could not be isolated 
from the reaction mixture by crystallization
2d                                             90                   74                57
Products (Yields)
2'a-h              2''a-h           2'''a-h
2fa                                            88                    59               47
2g                                            88                    b                 31
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2.4 Natural Product Target – Prostaglandins 
 In Scheme 2.8 below, we would like to emphasize the appeal of the hetero 
Pauson-Khand reaction. Three new bonds and two new asymmetric centers are formed in 
one step. It is clearly apparent to see the similarities between the product of the hetero 
Pauson-Khand reaction and the particular prostaglandin we are interested in synthesizing, 

























R'' = Alcohol Protecting Group
 
Scheme 2.7 Similarities between Prostaglandins and HPK Products 
F-type prostaglandins possess an additional center of asymmetry at C-9. 
Oxidation of F-type prostaglandins while the C-11 and C-15 sites are selectively 
protected provides a convenient access to PGEs. Since the E-type prostaglandins can, in 
turn, be readily converted to any other member of the same class, this makes the F-type 
prostaglandins highly attractive synthetic targets. Previous work (Table 2.1) in our 
laboratory has demonstrated not only a synthetic value of tandem reductive cyclization – 
carbonylation reactions in the preparation of complex molecules but also the interesting 
stereoselectivity observed therein. We now wish to feature PGF2α, as our representative 
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molecule to describe the exciting development of utilizing the hetero Pauson-Khand 
methodology as a convenient and flexible approach to the synthesis of prostaglandins and 
other structural analogs. 
2.5 Proposed Synthesis 
Our present goal for the hetero Pauson-Khand reaction would be to provide us 
with prostaglandin precursors using a stoichiometric equivalent of Cp2Ti(PMe3)2, in 
combination with known trends in the diasteroselective freatures of this reaction.2.14 
Based on this hetero Pauson-Khand strategy, we hope to be able to efficiently access the 































R = Alcohol Protecting Group




























Scheme 2.8 Retrosynthetic Cyclocarbonylation Route to Prostaglandins 
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Prior to the installment of the respective α- and γ- side chains, 2.0h and 2.0i, we plan to 
convert 2.0b to the aldehyde 2.0b' via ozonolysis in methanol at -78 oC followed by 
treatment with dimethyl sulfide.2.15 The aldehyde 2.0b', which is essentially Corey’s 
lactone, will then be transformed into PGF2α, 2.0a via the usual procedures common to 
many syntheses of prostaglandins; the Horner-Wadsworth-Emmons reaction to install the 
γ-side chain 2.0h and trans olefin followed by diastereoselective reduction of the 
conjugated ketone to give the allylic α-oriented alcohol.2.10  
Protection of that alcohol followed by DIBAL opening of the lactone will provide 
us the ability to connect the α-side chain 2.0i via a Wittig reaction.2.10 Subsequent 
deprotection steps should yield our desired product 2.0a. Substrate 2.0c will be prepared 
to test this idea of using diastereotopic group selectivity to set the C-12 stereocenter. The 
chiral substrate 2.0c, in an enantiomerically pure form, can be easily accessed using the 
method of Ito,2.16 which combines a five-carbon conjugated diene, 2.0f, with an aldehyde 
2.0d to give the pentadienylborane reagent 2.0g using the bromoborane reagent 2.0e, the 
preparation of which is known.2.17  
It is hoped that, if the hetero Pauson-Khand cyclization of the deconjugated dienol 
2.0c gives the expected diastereoselectivity, we would then be able to access it in high 
enantiomeric excess (ee) in order to achieve the synthesis enantiomerically.  
2.6 Selectivity 
 From the outset, our endeavor seemed to have anticipated that the control of the 
absolute configuration of the three new stereogenic centers would be dictated by substrate 
2.0c carrying a sterically-bulky protecting hydroxyl group of a fixed stereochemistry and 
nature of the stereoselection of the cycloaddition. This, however, is simply a hypothesis 
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and is the basis of our inquiry into establishing a new and promising area of possibly 
highly diastereoselective hetero Pauson-Khand reactions. Metallacycles 2.0c' and 2.0c'' 
modeled after the proposal outlined in Scheme 2.9 seem to provide hope that the correct 



















































R =  Alcohol Protecting Group
 
Scheme 2.9 Group Selective Reactions 
The hetero Pauson-Khand reaction of 2.0c is expected to favor diastereomer 2.0b, since 
both substituents can adopt preferred pseudoequatorial positions in the metallacycle 
intermediate 2.0c' leading to the desired product. The metallacycle diastereomer 2.0c'' 
leading to the undesired product 2.0b'' should be less favorable since the alkoxy 
substituent is forced to occupy a pseudoaxial position. 
Again, it is important to emphasize that the crucial component of this strategy is 
clearly the diastereoselectivity of the hetero Pauson-Khand cyclization, so the initial goal 
was to test this, in racemic form prior to proceeding with construction of any 
enantiomerically pure substrates. We decided to use a tert-butyldimethylsilyl group 
(TBDMS) as our alcohol protecting group. This silyl protecting group is a commonly 
used hydroxyl protecting group in prostaglandin synthesis. 
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2.7 Preparation of Prostaglandin Precursors 
 In order to examine the influence of the alcohol protecting group on 
diastereotopic group selectivity, compound 2.1p was proposed. The retrosynthetic 

















Scheme 2.10 Retrosynthetic Analysis of TBDMS Protected Aldehyde 2.1p 
Preparation of 2.1k2.18 commenced with the synthesis of 2.1j2.19 (Scheme 2.11). We 
initially prepared it from acrolein 2.1g and vinyl bromide 2.1h with an excess amount of 
magnesium in a 4:1 mixture of THF-Et2O. However, the yield of this reaction was low, 

















Scheme 2.11 Synthesis of Bromide 2.1k 
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Next, the synthesis of 2.1f2.20 was performed (Scheme 2.12). The acetal 2.1c, was derived 
from 1,3-propanediol 2.1a and benzaldehyde 2.1b by azeotropic removal of water via a 
Dean-Stark set-up. The acetal 2.1c was then reduced to the alcohol 2.1d with borane, 

























Scheme 2.12 Synthesis of Aldehyde 2.1f 
With substrates 2.1k and 2.1f at hand, we were now ready for our first convergency 
which is the pentadienylation reaction. A variety of convenient protocols exist for this 
transformation.2.21 We selected the indium mediated pentadienylation method. 2.22 This 
reaction is actually quite unique in that we obtain exclusively the γ-pentadienylation 
product. We believe that this selectivity is obtained through a cyclic six-membered 
transition state, where an aldehyde coordinates with the indium metal center and reacts in 
















Scheme 2.13 Indium Mediated Pentadienylation 
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Therefore, following our pentadienylation reaction, (Scheme 2.14) we obtained the 
benzyl protected alcohol 2.1l which in turn underwent protection with TBDMS-Cl to 
























Product Ratio: 1o : 2o alcohol   










Scheme 2.14 Observed Silyl Migration  
We next employed sodium-liquid ammonia reducing conditions2.24 to promote 
debenzylation of 2.1m. Unfortunately, instead of a sole primary alcohol product, we 
obtained a mixture of 2.1o and 2.1n in a 1:5 ratio. The emergence of 2.1n is explained by 
1,3-silyl migration2.25 which occurs during the debenzylation of 2.1m as a result of the 
formation of an alkoxide intermediate. Hence, we decided to return to substrate 2.1l and 
utilize the already present benzyl protecting group. Accordingly, 2.1l was subjected to 
DDQ oxidation2.26 followed by selective DIBAL opening2.27 on the less hindered side of 
the acetal 2.1p. PCC oxidation in DCM furnished our new desired target 2.1r (Scheme 
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Scheme 2.15 Synthesis of Benzyl Protected Aldehyde 2.1r 
oxidation of the acetal 2.1p) were also identified. With compound 2.1r at hand, we 
treated it with Cp2Ti(PMe3)2 and formed two diastereomeric metallacyclic compounds 
2.1s and 2.1t in a 1:1 ratio confirmed by  1H NMR data (Scheme 2.16).  To verify the 
correct stereochemistry, a solid sample mixture of these two new metallacycles was 
submitted for crystal X-ray analysis and the results indicated that both diastereomers had 



















Scheme 2.16 Preparation of Metallacycles 2.1s and 2.1t 
  
 
Figure 2.2 ORTEP Plot of Co-Crystallized Metallacycles 2.1s and 2.1t 
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The metallacycles were subjected to carbonylation conditions of 20 psi of CO at room 
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Scheme 2.17 Synthesis of Lactones 2.1u and 2.1v 














Benzyl (OBn) TBDPS Trityl
INCREASING BULK  
Scheme 2.18 Choice of Protecting Groups 
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Seeing that we are not achieving any sort of selectivity with the benzyl protecting 
group, we decided next to explore bulkier alcohol protecting groups (Scheme 2.18). The 
retrosynthetic analysis (Scheme 2.19) lays out a route where silyl group transfer is 
avoided due to the fact that deprotecting conditions for 2.2f do not generate an alkoxide 














































Scheme 2.20 Synthesis of Aldehyde 2.2d 
Following indium mediated pentadienylation of 2.2d and 2.1k, the PMB protected 
secondary alcohol 2.2e was then protected with our second choice of alcohol protecting 
groups towards diastereoselective optimization: TBDPSCl.2.23 Next, the p-methoxy 
benzyl-protecting group was cleaved off by treating 2.2f with DDQ2.28 to furnish the 



































Scheme 2.21 Synthesis of TBDPS Protected Aldehyde 2.2h 
We subsequently subjected the aldehyde 2.2h to reductive coupling conditions. While the 
coupling reaction in pentane yielded a mixture of two metallacylic compounds 2.2i and 
2.2j in a ratio of ca. 2:1, almost no selectivity was afforded in THF (Scheme 2.22). 
Initially, the complexity in the 1H-NMR of the mixture and relatively less crystalline 
property of 2.2i precluded us from formally deducing its structure. However, we were 
able to isolate a crystal structure of the undesired metallacycle 2.2j (Figure 2.3)(Entry 1).  
Henceforth, we then turned our attention to the subsequent carbonylation reaction 

















Entry            Reaction Conditions                                               Yieldb
Ratio of Metallacyclesa
2.2i:2.2j
1      1.0 equiv. Cp2Ti(PMe3)2, Pentane     ~ 2:1                       88%
 2      1.0 equiv. Cp2Ti(PMe3)2, THF           ~ 1:1                       92%




Scheme 2.22 Results from Synthesis of Metallacycles 2.2i and 2.2j 
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Figure 2.3 ORTEP Plot of Metallacycle 2.2j 
We were a little surprised at the change in metallacyclic ratios when going from pentane 
to THF. Unfortunately we do not have a firm explanation or hypothesis on this observed 
solvent effect on the metallacycle ratio at this point. Devising mechanistic studies in the 
future could lead to clarification of this outcome. The metallacyclic mixture of 
diastereomers 2.2i and 2.2j obtained from the reaction involving conditions in Entry 1 
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were subjected to varying carbonylation conditions and the results are summarized below 
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  20 psi
2.2i :2.2j
2.2k 2.2l
Entry            Reaction Conditions
   Ratio of lactonesa
2.2k:2.2l
1                Pentane, 25 oC, 12 h             ~ 1.25:1               39%:31%








Scheme 2.23 Results from Synthesis of Lactones 2.2k and 2.2l 
Here again, we observed that the lactone ratios changed from that of the metallacyclic 
ratio. Possible explanations for this are that the reductive coupling step is reversible or 
that one of the metallacycles is decomposing while the other reacts faster. These results 
however, definitely indicate that further investigation into the trityl group is required. 
2.9 Synthesis of the Trityl-Protected Prostaglandin Precursor 
 Initial experiments to synthesize 2.3d were carried out with compound 2.2e. An 
attempted protection of the secondary alcohol with triphenylmethyl chloride2.29 and DBU 
as base was unsuccessful. We then tried conditions utilizing triphenylmethylpyridinium 
tetrafluoroborate2.30 in MeCN and the best yield obtainable was 10%, which was 
unacceptable. We recognized that a stronger tritylating reagent would have to be 























2.3b 2.3c  
Scheme 2.24 Attempted Tritylation Procedures 
reagent; triphenylmethyl perchlorate (Scheme 2.24).2.31 When we subjected compound 
2.2e to the tritylating conditions described in Scheme 2.25, we obtained an alcohol 
product (tentatively assigned from 1H NMR data) with an unusually high Rf value. We 
believe that the trityl perchlorate reagent 2.3c oxidatively cleaved the PMB group, 
however we were not sure if it was the 1o or 2o alcohol product remaining. We therefore 
submitted the sample to PCC oxidation and verified the subsequent product as the ketone 




























Scheme 2.25 Tritylation of Alcohol 2.2e 
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It appeared to us that further investigations into tritylating 2.2e would be futile, so 














Scheme 2.26 Attempted Synthesis of Primary Alcohol 2.3d 
The tritylation step to transform the secondary alcohol 2.1l to 2.3g went smoothly and 
uneventfully, but the next crucial step of debenzylation, however, did not yield the 
desired alcohol 2.3d. Instead, the sodium-liquid ammonia conditions afforded a complex 
reaction mixture and in retrospect, this observation is understandable since it is known 
that some detritylation procedures employ reduction treatment with sodium in liquid 
ammonia.2.32  
We plotted out a retrosynthetic analysis, illustrated in Scheme 2.27 where the 
position originally occupied by the benzyl derived protecting groups would now be 




2.3d 2.3k 2.3j  
Scheme 2.27 Retrosynthetic Analysis of Primary Alcohol 2.3d 
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The synthesis of 2.3l proceeded without any difficulty starting with the commercially 
available mono TBS-protected propanediol 2.3h. Familiar reactions were repeated and 
much to our delight, TBAF deprotection of the silyl protecting group yielded compound 

































Scheme 2.28 Synthesis of Trityl Protected Aldehyde 2.3l 
During PCC oxidation of 2.3d, we observed cleavage of the trityl group due to the slight 
acidic nature of the reaction solution. As a result, an equivalent amount of sodium acetate 
was added to buffer the reaction solution and cleanly afford enal 2.3l.2.33   
Reductive coupling of 2.3l commenced under the conditions employed in synthesizing 
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(37%)                          (18%)                           (19%)
25 oC, Pentane
2.3l 2.3m 2.3n 2.3o
~2:1:1 Selectivity  
Scheme 2.29 Reductive Coupling and Carbonylation of 2.3l 
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A mixture of metallacycles was obtained. It proved difficult to isolate and characterize 
each metallacycle. Therefore, we followed through with the carbonylation step and 
obtained approximately a 2:1:1 (determined by crude 1H NMR data) mixture of the three 
diastereomeric lactones 2.3m, 2.3n and 2.3o. 
 
Figure 2.4 ORTEP Plot of Co-Crystallized Metallacycles 2.3n and 2.3o 
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The two minor diastereomers 2.3n and 2.3o were not separable by TLC, but were 
individually visible by analytical HPLC. After subjecting the crude mixture to column 
chromatography, the major product lactone 2.3m was separated and characterized. The 
identities of the minor products were ascertained by recrystallization and confirmed by 
X-ray crystallography (Figure 2.4). Both diastereomers co-crystallized within a single 
crystal structure. This study has established the difficulty in obtaining the desired 
diastereoselectivity based solely on the size of the protecting alcohol group. However, we 
decided to try one more idea which involved completely converting the alcohol 
functionalilty into a bulky silyl group. We believed that the shorter distance and increased 
steric bulk may contribute to enhancing the diastereoselectivity of the hetero Pauson-
Khand reaction. If good selectivity could be achieved with this reaction, then the correct 
stereochemical relationship of the silyl group (2.4c) to the rest of the molecule would be 





















Scheme 2.30 Retrosynthetic Analysis Outlining the Synthesis of 2.4a 
2.10 Switching from Hydroxyl to Silyl Functionality 
First, the reaction of the silyllithium reagent should proceed with complete 
inversion of configuration. Afterward, following the hetero Pauson-Khand reaction, the 
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phenyl groups would be converted to alkylalkoxy groups.2.34a This would be followed by 
oxidative cleavage of the carbon-silicon bond with trimethylamine-N-oxide where the 
















2.4c 2.4c' 2.4c''  
Scheme 2.31 Proposed Oxidative Cleavage of Silicon-Carbon Bond 
To this end, we synthesized the triphenylsilyl lithium reagent 2.4e by stirring a 
THF solution of triphenylsilyl chloride with lithium metal.2.35 We determined the 
molarity of the silyllithium solution 2.4e by titration with standard BHT solution with 
9,10-phenanthroline as indicator. Tosylation of compound 2.2e provided compound 2.4f. 
This was then reacted with the freshly prepared silyl lithium reagent 2.4e via a normal 

























Scheme 2.32 Attempted Substitution of Tosylate 2.4f 
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Unfortunately, no substitution occurred and we only obtained the eliminated product, 
2.4g. We also prepared the silyl lithium reagent (Ph2tBuSiLi) and silyl cuprate reagent 
(Ph2tBuSi)2CuLi,2.37 but these reagents still only afforded the eliminated product 2.4g. 
2.11 Other Synthetic Applications 
At this point, we decided to take a step back and take a broad look at the project 
and determine if there were any other potential lactones that could be formed based on 
the knowledge that we had just gleaned from all the reactions performed so far. Methyl 
jasmonate, 2.5g, a main component of jasmine oil,2.38 is structurally similar to that of 
medicinally important prostanoids, for example, PGE2, 2.5h (Figure 2.5).  Therefore, any 
knowledge that has been acquired in the synthesis towards prostaglandin analogs could 








Figure 2.5 Similarities between Methyl Jasmonate 2.5g and PGE2 2.5h 
2.12 Synthesis Towards Methyl Jasmonate 
 Methyl jasmonate belongs to the jasmonoid group, which are 2,3-disubstituted 
five-membered cyclic ketones. They are the most important representatives of natural 
jasmine fragrances which are isolated from jasmine flowers. Jasmonoids not only exhibit 
characteristic fragrance properties, but also play a key role in phytohormones in plants.2.39 
This range of plant regulatory and pheromonal properties has attracted attention to methyl 
jasmonate as an important synthetic target.2.40 
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We now wish to propose the preparation of methyl jasmonate as illustrated in the 








Scheme 2.33 Retrosynthetic Analysis of Methyl Jasmonate 2.5g 
Our synthesis starts with the already available 2.3j which was synthesized earlier 
for the preparation of the trityl-protected enal 2.3l. Mesylation of the secondary alcohol 
proceeded easily, as well as the LAH reduction2.41 of the mesyl function. Following the 
latter reaction, we encountered an unexpected surprise, evidenced by the loss of the 
TBDMS group, which actually then saved us a step (deprotection). We believe that the 
loss of the TBS group occurred during the aqueous work-up of compound 2.5a'. PCC 

























Scheme 2.34 Synthesis of Aldehyde 2.5c 
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Reductive coupling of 2.5c with 1.0 equivalent of Cp2Ti(PMe3)2 in pentane yielded the 
desired metallcyclic diastereomer 2.5d exclusively. Carbonylation of metallacycle 2.5d 





















Scheme 2.35 Synthesis of Lactone 2.5e 
Other than just serving as a jasmonoid precursor, 2.5e can also be converted to 11-
deoxyprostaglandins, such as 11-deoxy PGF1α (Scheme 2.36). This class of 
prostaglandins are known to inhibit gastic acid secretion and can cause uterine 











Scheme 2.36 Route towards 11-deoxy PGF1α 2.5f Synthesis 
We would however like to propose the total synthesis of methyl jasmonate 2.5g in 
Scheme 2.37. The primary alcohol 2.5i can be very easily obtained by hydroboration of 
2.5e with 9-BBN at 0 oC followed by in situ oxidation of the intermediate alkylboron 
with H2O2. DIBAL reduction of the lactone to the corresponding lactol and a subsequent 
Wittig reaction would provide the skeletal framework 2.5k for jasmonoid and prostanoid 
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derivatives. Further oxidation to the carboxylic acid by using Jones’ reagent and 
































Scheme 2.37 Proposed Synthesis of Methyl Jasmonate 2.5g 
This proposed preparation constitutes a formal synthesis of the natural product, methyl 
jasmonate 2.5g in racemic form.  
2.13 More Possibilities! 
The exclusive diastereoselectivity exhibited by lactone 2.5e, stirred a curiosity in 
us to explore substrates 2.6a and 2.7a (Figure 2.6) which are structurally similar to 
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Figure 2.6 Proposed Structures 2.6a and 2.7a 
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In the cases of aldehyde substrates 2.6a and 2.7a, we wondered what type of 
chemoselectivity the titanocene reagent [Cp2Ti(PMe3)2] would exhibit in the hetero 
Pauson-Khand reaction. After coordinating with the aldehyde group, would the titanium 
center proceed to react with the alkyne selectively? or with the alkene? or both? This 
investigation will shed interesting light on the reactivity of alkyne versus alkene 
functionalities in titanium mediated reductive cyclizations. The racemic synthesis of 2.7a 
can be easily obtained from synthetic intermediates of 2.6a. Hence, we commenced this 
venture by proposing the racemic synthesis of 2.6a (Scheme 2.38).  We began by treating 














































Scheme 2.38 Initial Proposed Synthesis of Aldehyde 2.6a 
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for 3 h to afford alcohol 2.6d.2.43 Treatment of alcohol 2.6d with EtMgBr at 0 oC in THF, 
followed by the addition of TMSCl yielded the alcohol 2.6d'.2.44 Treatment of alcohol 
2.6d' with 1.1 equiv. of NBS and 1.2 equiv. of PPh3 in DCM at 0 oC yielded the bromide 
2.6e.2.44 Indium mediated reaction analogous to the pentadienylation of 2.1k was used 
next to prepare the 1:1 mixture of diastereomers, 2.6f and 2.6f'. This lack of selectivity 
indicates that a more selective pentadienylation reaction would be necessary for the 
synthesis of 2.7a. Mesylation of the mixture of diastereomers unfortunately resulted in 
the elimination product 2.6g. We believe that this elimination which is absent when the 
alkyne is replaced with an alkene, is due to the overlap of the alkyne π-orbitals with that 
of the C-H bond thus facilitating elimination. At this point, we envisioned that the effect 




















































Scheme 2.39 Synthesis towards Aldehyde 2.6a 
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We decided to test the idea by first synthesizing the 1:1 diastereomeric mixture of TBS 
protected alcohols 2.6i and 2.6i'. Next, we formed the hexacarbonyldicobalt-alkyne 
complexes 2.6j and 2.6j' by reacting with 1.0 equiv. of Co2CO8 in DCM.2.45 Much to our 
delight, the much anticipated mesylation reaction of 2.6j and 2.6j' occurred smoothly to 
afford the mesylated products. Decomplexation of the mesylated Co-acetylene complexes 
2.6k and 2.6k' with ceric ammonium nitrate (CAN) in anhydrous MeOH not only freed 
the alkyne, but also enabled the deprotection of the TBS protecting group.2.46 LAH 
reduction of the mesyl function produced the alcohol 2.6l and PCC oxidation furnished 























Scheme 2.40 Synthesis of Aldehyde 2.6a 
2.14 Conclusion 
We are currently applying titanium mediated reductive coupling conditions to substrate 
2.6a. We have also began to investigate exploitation of 2.5e as a synthon to synthesize 
methyl jasmonate 2.5g. Going back to our original hypothesis, changing the reaction 
conditions and protecting groups brought the ratio up to 1.25:1, but no higher. Hence, 
while the methodology described in this project appears to be reasonably versatile in that 
it allows for easy access to the prostaglandin lactone precursors, there is still the need to 
improve the selectivity. We will still continue to look into different conditions that may 
enhance the diastereoselectivity with respect to the hetero Pauson-Khand reaction.  
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2.15 Experimental Section 
2.15.1 General Methods 
 All experiments were performed under a nitrogen atmosphere in oven- and/or 
flame-dried glassware using a Vacuum Atmospheres dry-box or by using standard 
Schlenk techniques.  Solvents used as reaction media were distilled immediately before 
use:  Et2O, THF, benzene and toluene were distilled from Na/benzophenone ketyl. 
Pentane is distilled from Na/benzophenone ketyl/tetraglyme. DCM was distilled from 
calcium hydride. Carbon monoxide of 2.3 grade (99.3%) was purchased from BOC 
Gases, New Jersey. Cp2Ti(PMe3)22.47 and PMe32.48 were prepared as described in 
literature. Titanocene dichloride was purchased from Alfa Chemicals.  Other reagents 
were purified by simple distillation or by passing through a short column of activated 
alumna or silica gel. 
 1H and 13C NMR spectra were recorded on a Bruker 250 and 300 MHz 
spectrometers in deuterated solvents using the solvent carbon or residual protons (CHCl3: 
7.27 ppm 1H, 77.23 ppm 13C, C6D6: 7.15ppm 1H, 128.0 ppm 13C) as an internal reference.  
NMR solvents were dried over 4Å molecular sieves or by passing through a short column 
of activated alumina. Chemical shifts (δ) are given in parts per million down from 
tetramethylsilane (TMS). Data for 1H NMR spectra are reported as follows: chemical 
shift (δ ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, quin = quintet, 
dd = doublet of doublets, dt = doublet of triplets, ddd = doublet of doublet of doublets, 
ddt = doublet of doublet of triplets, m = multiplet), coupling constant (Hz), and 
integration. Elemental analyses (%C, %H) were determined by Huffman Laboratories, 
Inc., Golden, Colorado. Analytical thin layer chromatography (TLC) was performed on 
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Scientific Adsorbent Company Inc. silica gel plates. Components were visualized by 
illumination with long wave ultraviolet light, exposure to iodine vapor, or by standing 
with one of the following reagents (followed by heating): p-anisaldehyde (or vanillin) in 
ethanol/sulfuric acid and 7% phosphomolybdic acid in ethanol. Solvents for extraction 
and chromatography were reagent grade and used as received.  Flash column 
chromatography was performed using Scientific Adsorbent Company Inc. silica gel (32-
63 m). Brine refers to a saturated aqueous solution of NaCl.  NH4Cl and NaHCO3 refer to 
saturated aqueous solutions unless otherwise specified. 






Penta-1,4-dien-3-ol (2.1j). 2.1j was prepared from vinylmagnesium bromide 2.1i (66.9g, 
510.0 mmol), and acrolein 2.1g (23.6, 420.0 mmol) in THF/ether (4:1) at -15 oC for 3 h. 
After quenching the reaction mixture with saturated ammonium chloride at 0 oC, 
followed by filtering off the inorganic precipitate on Celite. 2.1j was obtained by 
fractional distillation; 23.7g (67%), b.p. 116 oC/760 mm Hg. 1H NMR (250 MHz, 
CDCl3): δ 5.90-5.81 (m, 2H), 5.29-5.11 (m, 4H), 4.60 (m, 1H), 1.77 (br s, 1H); 13C NMR 
(62.5 MHz, CDCl3): δ 139.5, 115.7, 74.4. 
Br
OH 48% HBr
2.1j 2.1k  
(E)-5-bromopenta-1,3-diene (2.1k). 41.1 mL of a 48% aqueous solution of HBr was 
added dropwise to a neat pre-cooled solution (0 oC) of 2.1j (20.4 g, 242.7 mmol). After 
the resulting yellow solution was stirred for 1 h, ether (100 mL) was added. The organic 
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layer was extracted and washed with NaHCO3 (100 mL). The organic layer was dried 
with Na2SO4 and distilled (54-55 oC/34 mm Hg) to give 24.9 g (70 %) of 2.1k. 1H NMR 
(300 MHz, CDCl3): δ 6.37-6.32 (m, 2H), 5.95-5.87 (m, 1H), 5.39-5.19 (m, 2H), 4.08-4.05 









2.1a 2.1b 2.1c  
2-Phenyl-1,3-dioxane (2.1c). 1,3-Propanediol 2.1a (76.1 g, 1 mmol) was dissolved in 
toluene (250 mL) and treated with benzaldehyde 2.1b (106 g 1 mmol) and a catalytic 
amount of p-toluenesulfonic acid monohydrate (300 mg). The resulting solution was 
stirred at reflux under a Dean-Stark trap until the theoretical amount of water had 
separated (3 h). The acetal was extracted with ether (3 x 100 mL) and washed with 
NaHCO3 (100 mL). It was then dried over MgSO4, filtered and concentrated under 
reduced pressure to yield 157 g (96%) of 2.1c as a white crystalline solid. The crude 
acetal was used directly in the subsequent reduction. 1H NMR (250 MHz, CDCl3): 
δ 7.49-7.45 (m, 2H), 7.36-7.32 (m, 3H), 5.49 (s, 1H), 4.29-4.22 (dd, J = 11.9 Hz, J = 5.0 
Hz, 2H), 4.03-3.92 (td, J = 12.3 Hz, J = 2.5 Hz, 2H), 2.36-2.10 (m, 1H), 1.46-1.39 (dt, J 









3-(Benzyloxy)propan-1-ol (2.1d). To a neat sample of 2.1c (6 g, 36.5 mmol) in a round- 
bottom flask, was added 219 mL, (219 mmol) of 1M BH3·THF, while cooling the 
solution with an ice bath. The mixture was stirred overnight and then quenched slowly by 
adding 50 mL of water. The reaction mixture was then filtered through Celite and the 
combined filtrate and washings were concentrated to 6.0 g (99%). This was used without 
purification in the following step. 1H NMR (250 MHz, CDCl3): δ 7.36-.29 (m, 5H), 4.50 
(s, 2H), 3.80-3.73 (q, J = 5.5 Hz, 2H), 3.67-3.62 (t, J = 11.5 Hz, 2H), 2.30-2.25 (t, J = 5.5 
Hz, 1H), 1.81-1.80 (m, 2H); 13C NMR (62.5 MHz, CDCl3): δ 138.4, 128.8, 128.1, 128.1, 
73.7, 69.9, 62.4, 32.5. 
O OH O H
OPCC
 Al2O3 
DCM2.1d 2.1f  
3-(Benzyloxy)propanal (2.1f).To a suspension of PCC (11.7 g, 54.6 mmol) in CH2Cl2 
was added neutral Al2O3 (11.7 g) at room temperature. After 30 min stirring, the alcohol 
2.1d (4.5 g, 27.3 mmol) was added, and then further stirring for 2 h during which time the 
reaction mixture turned a dark black in color. The reaction mixture was diluted with ether 
and filtered through a plug of dry silica gel. The solvent was evaporated under reduced 
pressure. Purification by column chromatography (silica gel, pentane/ethyl ether, 80/20) 
yielded the product 2.1f (4.03 g, 90%) as a colorless liquid. 1H NMR (250 MHz, CDCl3): 
δ 9.79-9.77 (t, J = 1.77 Hz, 1H), 7.33-7.24 (m, 5H), 4.51 (s, 2H), 3.82-3.77 (t, J = 6.1 Hz, 
2H), 2.71-2.65 (td, J = 6.0 Hz, J = 1.8 Hz, 2H); 13C NMR (62.5 MHz, CDCl3): δ 201.6, 









2.1f 2.1k 2.1l  
1-(Benzyloxy)-4-vinylhex-5-en-3-ol (2.1l). Indium powder, (100 mesh, 4.26 g, 37.1 
mmol) was added to a solution of 2.1k (10.9 g, 74.2 mmol) in DMF (60 mL). The 
solution was cooled to 0 oC and the carbonyl compound 2.1f (6.1 g, 37.1 mmol) in DMF 
(30 mL) was added. The reaction was stirred for 3 h at 0 oC, then diluted with water (50 
mL) and extracted with ether (3 x 50 mL). The organic extracts were washed with a 
saturated solution of CuSO4 (100 mL), dried (MgSO4), filtered and concentrated in 
vacuo. Purification by column chromatography (silica gel, hexanes/EtOAc, 95:05) 
yielded the product 2.1l (8.45 g, 98%) as a colorless oil. 1H NMR (250 MHz, CDCl3): δ 
7.39-7.33 (m, 5H), 5.90-5.80 (m, 2H), 5.20-5.09 (m, 4H), 4.52 (s, 2H), 3.81-3.65 (m, 
3H), 2.85-2.80 (m, 2H), 1.81-1.74 (m, 2H); 13C NMR (62.5 MHz, CDCl3): δ 138.3, 
138.0, 137.5, 128.8, 128.1, 117.4, 117.1, 73.7, 73.2, 69.4, 55.2, 34.2. 
O
OH






4-(Penta-1,4-dien-3-yl)-2-phenyl-1,3-dioxane (2.1p). In a 50 mL round-bottom flask, 
DDQ (4.77 g, 21.0 mmol) and Na2SO4 (5 g) were suspended in DCM (100 mL) and 
stirred for 1 h. Alcohol 2.1l (4.887 g, 21.0 mmol) in DCM (10 mL) was cannulated into 
the DDQ mixture. The reaction mixture immediately turned greenish-black, then faded to 
a chocolate brown after about 10 min. The reaction was quenched after 3 h with the 
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addition of sat. Na2SO3 (50 mL). The mixture was stirred until the solution became 
yellow. The slurry was then filtered through a Celite pad and rinsed multiple times with 
ether (50 mL total) and sat. NaHCO3 (50 mL total). The aqueous layer was reextracted 
with ether (3 x 20 mL). The combined ethereal layers were washed with sat. NaHCO3 (30 
mL), dried over Na2SO4, filtered and concentrated under reduced pressure. Column 
chromatography (silica gel, hexanes/EtOAc, 95:05) yielded the purified product 2.1p 
(1.45 g, 30%) as a colorless oil. 1H NMR (250 MHz, CDCl3): δ 7.51-7.34 (m, 5H), 6.05-
5.80 (m, 2H), 5.51 (s, 1H), 5.18-5.10 (m, 4H), 4.27-4.20 (m, 1H), 4.01-3.84 (m, 2H), 
3.01-2.95 (m, 1H), 1.92-1.82 (m, 2H); 13C NMR (62.5 MHz, CDCl3): δ 139.2, 137.3, 
137.2, 129.0, 128.5, 126.4, 117.3, 117.0, 101.4, 67.4, 53.5, 29.3. Anal. Calcd for 




2.1p 2.1q  
3-(Benzyloxy)-4-vinylhex-5-en-1-ol (2.1q). To a solution of 2.1p (2.0 g, 8.68 mmol) in 
DCM (50 mL) at -78 oC was added dropwise a solution of DIBAL (52.1 mL, 1.0 M 
solution in hexanes, 52.1 mmol). After 3 h at -78 oC, the cold reaction mixture was 
poured into a saturated aqueous solution of Rochelle’s salt (20 mL). The mixture was 
diluted with DCM (20 mL) and after 2 h of stirring at room temperature, the two phases 
were separated. The aqueous layer was extracted with more DCM (20 mL) and the 
combined organic extracts were washed with brine, dried over MgSO4, filtered and 
concentrated under reduced pressure. Column chromatography (silica gel, 
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hexanes/EtOAc, 70:30) yielded the purified product 2.1q (1.99 g, 99%) as a colorless oil. 
1H NMR (250 MHz, CDCl3): δ 9.78-9.77 (t, J = 1.67 Hz, 1H), 7.32 (s, 5H), 5.91-5.82 (m, 
2H), 5.21-5.11 (m, 4H), 4.66-4.53 (q, J = 11.3 Hz, 2H), 4.05-4.02 (m, 1H), 3.14-3.11 (m, 
1H), 2.70-2.60 (m, 2H); 13C NMR (62.5 MHz, CDCl3): δ 138.5, 137.5, 137.3, 128.9, 
128.3, 128.2, 117.3, 117.2, 81.1, 72.3, 61.0, 51.4, 34.0. Anal. Calcd for C15H20O2: C, 









3-(Benzyloxy)-4-vinylhex-5-enal (2.1r). The procedure analogous to that used for 2.1f 
afforded the product 2.1r (1.42 g, 90% yield from the alcohol 2.1q on a 6.86 mmol scale) 
as a colorless oil. Column chromatography (silica gel, hexanes/EtOAc, 90:10). 1H NMR 
(250 MHz, CDCl3): δ 7.35 (s, 5H), 6.05-5.79 (m, 2H), 5.19-5.09 (m, 4H), 4.72-4.50 (m, 
2H), 3.76-3.69 (m, 3H), 3.10-3.25 (m, 1H), 1.81-1.74 (q, J = 6.23 Hz, 2H); 13C NMR 
(62.5 MHz, CDCl3): δ 201.5, 138.4, 137.0, 136.8, 128.8, 128.2, 128.1, 117.9, 117.8, 77.3, 


















Metallacycles (2.1s) and (2.1t). To a solution of Cp2Ti(PMe3)2 (0.43 g, 1.3 mmol) in 
THF (5 mL) was added enal 2.1r (0.3 g, 1.3 mmol) inside an argon filled glove box. 
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After stirring for 2 h at room temperature, the reaction mixture was filtered through a pad 
of Celite and rinsed with pentane to give a reddish-brown solution. THF was removed 
under reduced pressure and the reddish-brown solid residue was obtained as the 
inseparable 1:1 mixture of compound 2.1s and 2.1t (0.329 g, 91%). H NMR (300 MHz, 
C6D6): δ 7.53-7.46 (m, 4H), 7.34-7.28 (m, 4H), 7.25-7.21 (m, 2H), 6.42-6.32 (m, 1H), 
5.98 (s, 10H), 5.93 (s, 5H), 5.92 (s, 5H) 5.44-5.26 (m, 5H), 4.93-4.90 (m, 1H), 4.67-4.58 
(m, 2H), 4.54-4.38 (m, 2H), 4.02-3.93 (m, 2H), 3.42-3.35 (m, 2H), 3.01-2.85 (m, 2H), 
2.76-2.70 (m, 1H), 2.30-2.24 (m, 2H), 2.98-2.89 (m, 1H), 2.80-2.70 (m, 1H), 1.37-1.26 
(m, 2H), 1.28-1.20 (m, 2H); 13C NMR (75 MHz, C6D6): δ 141.4, 139.9, 139.8, 139.4, 
132.6, 114.3, 114.0, 112.4, 112.3, 83.9, 82.1, 81.9, 81.1, 71.6, 71.0, 68.5, 68.4, 63.4, 62.7, 



















(2.1v). A glass (max. pressure: 70 psi) high pressure reactor was charged with the 
metallacyclic compounds 2.1s and 2.1t (0.25 g, 0.898 mmol) and pentane (20 ml), inside 
an argon filled glove box. After removing the reactor from the glove box, CO (20 psi) 
was introduced into the reactor. The reaction mixture was stirred for 12 h at room 
temperature, and then CO pressure was cautiously released inside a fume hood. The 
reaction mixture was filtered though a pad of silica gel, washed with Et2O (25 ml). A 
solution of the product in Et2O was stirred for 1h, and then concentrated under reduced 
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pressure. The crude residue was chromatographed on silica gel (hexanes/EtOAc, 80:20) 
yielded the titled lactones 2.1u (0.073 g, 41%) and 2.1v (0.072 g, 40%) in a 1:1 ratio as 
oils. Lactone 2.1u: 1H NMR (300 MHz, CDCl3): δ 7.34-7.25 (m, 5H), 6.06-5.94 (m, 1H), 
5.18-5.11 (m, 2H), 5.06-5.02 (m, 1H), 4.55-4.41 (m, 2H), 4.05-4.02 (m, 1H), 2.94-2.87 
(m, 1H), 2.78-2.29 (m, 2H), 2.54-2.46 (m, 1H), 2.32-1.96 (m, 2H); 13C NMR (75 MHz, 
CDCl3): δ 178.5, 139.7, 136.8, 129.9, 129.2, 118.2, 85.3, 84.8, 72.9, 57.0, 43.6, 38.5, 
36.4. Lactone 2.1v: 1H NMR (300 MHz, CDCl3): δ 7.40-7.30 (m, 5H), 5.78-5.67 (m, 1H), 
5.31-5.12 (m, 2H), 5.00-4.95 (m, 1H), 4.62-4.48 (m, 2H), 3.88-3.82 (m, 1H), 2.83-2.49 
(m, 4H), 2.35-2.14 (m, 2H); 13C NMR (75 MHz, CDCl3): δ 178.5, 139.5, 139.2, 129.9, 













2-(4-Methoxyphenyl)-1,3-dioxane (2.2b). The procedure analogous to that used for 2.1c 
afforded the product 2.2b (118 g, 92% yield from 2.2a on a 661 mmol scale) as white 
crystals. Recrystallization (hexanes/EtOAc, 70:30). 1H NMR (250 MHz, CDCl3): δ 7.44-
7.40 (d, J = 7.10 Hz, 2H), 6.91-6.88 (d, J = 7.10 Hz, 2H), 5.46 (s, 1H), 4.29-4.22 (dd, J = 
13.0 Hz, J = 4.9 Hz, 2H), 4.03-3.92 (td, J = 12.3 Hz, J = 2.5 Hz, 2H), 3.80 (s, 3H), 2.25-
2.19 (m, 1H), 1.47-1.40 (m, 1H); 13C NMR (62.5 MHz, CDCl3): δ 160.3, 131.7, 127.7, 










3-(4-Methoxybenzyloxy)propan-1-ol (2.2c). The procedure analogous to that used for 
2.1d afforded the product 2.2c (70.5 g, 98% yield from 2.2b on a 367 mmol scale) as 
colorless oil. Column chromatography (silica gel, hexanes/EtOAc, 55:45). 1H NMR (250 
MHz, CDCl3): δ 7.26-7.21 (d, J = 11.4 Hz, 2H), 6.89-6.84 (d, J = 11.4 Hz, 2H), 4.43 (s, 
2H), 3.78 (s, 3H), 3.75-3.70 (t, J = 5.7 Hz, 2H), 3.63-3.58 (t, J = 5.8 Hz, 2H), 1.87-1.78 












3-(4-Methoxybenzyloxy)propanal (2.2d). The procedure analogous to that used for 2.1f 
afforded the product 2.2d (10.0 g, 92% yield from the alcohol 2.2c on a 56 mmol scale) 
as a colorless oil. Column chromatography (silica gel, hexanes/EtOAc, 70:30). 1H NMR 
(250 MHz, CDCl3): δ 9.79-9.78 (t, J = 1.8 Hz, 1H), 7.27-7.23 (d, J = 11.4 Hz, 2H), 6.91-
6.86 (d, J = 11.4 Hz, 2H), 4.46 (s, 2H), 3.81 (s, 3H), 3.81-3.76 (m, 2H), 2.71-2.66 (m, 











2.2d 2.1k 2.2e  
1-(4-Methoxybenzyloxy)-4-vinylhex-5-en-3-ol (2.2e). The procedure analogous to that 
used for 2.1l afforded the product 2.2e (7.93 g, 96% yield from the aldehyde 2.2d on a 
31.4 mmol scale) as a colorless oil. Column chromatography (silica gel, hexanes/EtOAc, 
80:20). 1H NMR (250 MHz, CDCl3): δ 7.26-7.23 (d, J = 8.7 Hz, 2H), 6.89-6.85 (d, J = 
8.7 Hz, 2H), 5.97-5.75 (m, 2H), 5.18-5.06 (m, 4H), 4.45 (s, 2H), 3.80 (s, 3H), 3.70-3.61 
(m, 3H), 2.86-2.85 (d, J = 2.9 Hz, 1H), 2.90-2.70 (m, 1H), 1.82-1.65 (m, 2H); 13C NMR 
(62.5 MHz, CDCl3): δ 159.6, 138.0, 137.6, 130.4, 129.7, 117.4, 117.1, 114.2, 73.3, 69.1, 











tert-Butyl(1-(4-methoxybenzyloxy)-4-vinylhex-5-en-3-yloxy)diphenylsilane (2.2f). To 
a solution of 2.2e (3.62 g, 13.7 mmol) in dry DCM (30 mL) was added imidazole (1.87 g, 
27.5 mmol) followed by the addition of TBDPSCl (4.93 g, 17.9 mmol). The reaction 
mixture was stirred at room temperature for 12 h under an atmosphere of nitrogen. The 
reaction mixture was diluted with DCM (25 mL) and washed successively with water, 
brine and dried over Na2SO4. The organic layer was evaporated under reduced pressure.  
Column chromatography (silica gel, hexanes/EtOAc, 95:05) yielded the purified product 
2.2f (6.42 g, 93%) as a colorless oil. 1H NMR (250 MHz, CDCl3): δ 7.66-7.63 (m, 4H), 
7.37-7.32 (m, 6H), 7.10-7.06 (d, J = 8.6 Hz, 2H), 6.82-6.79 (d, J = 8.6 Hz, 2H), 5.94-5.81 
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(m, 2H), 5.06-4.83 (m, 4H), 4.14 (s, 2H), 3.92-3.90 (m, 1H), 3.78 (s, 3H), 3.33-3.22 (m, 
2H), 2.89-2.79 (m, 1H), 1.77-1.69 (m, 2H), 1.03 (s, 9H); 13C NMR (62.5 MHz, CDCl3): 
δ 159.4, 138.6, 137.2, 136.5, 136.4, 134.9, 134.3, 131.0, 130.0, 129.9, 129.5, 127.9, 











3-(tert-Butyldiphenylsilyloxy)-4-vinylhex-5-en-1-ol (2.2g). To a solution of 2.2f (4.89 
g, 9.7 mmol) in a mixture of DCM and water (20:1, 68 mL) was added DDQ (3.32 g, 
14.6 mmol) and the reaction mixture stirred at room temperature for 5 h. The reaction 
mixture was then diluted with DCM (30 mL) and washed successively with aqueous 
NaHCO3, water, brine and dried over Na2SO4. The organic layer was evaporated under 
reduced pressure to yield the crude product mixture which was prurified by silica gel 
chromatography using (hexanes/EtOAc, 90:10) to yield 3.32 g (90%) of 2.2g. 1H NMR 
(250 MHz, CDCl3): δ 7.72-7.67 (m, 4H), 7.41-7.36 (m, 6H), 6.05-5.67 (m, 2H), 5.27-4.92 
(m, 4H), 3.98-3.91 (m, 1H), 3.53-3.46 (m, 2H), 2.93-2.87 (m, 1H), 1.72-1.63 (m, 2H), 
1.07 (s, 9H); 13C NMR (62.5 MHz, CDCl3): δ 138.1, 137.3, 136.5, 136.4, 134.5, 134.1, 











3-(tert-Butyldiphenylsilyloxy)-4-vinylhex-5-enal (2.2h). The procedure analogous to 
that used for 2.1f afforded the product 2.2h (1.22 g, 88% yield from the alcohol 2.2g on a 
3.67 mmol scale) as a colorless oil. Column chromatography (silica gel, hexanes/EtOAc, 
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95:05). 1H NMR (250 MHz, CDCl3): δ 9.53-9.51 (t, J = 2.1 Hz, 1H), 7.72-7.63 (m, 4H), 
7.45-7.36 (m, 6H), 6.01-5.70 (m, 2H), 5.16-4.90 (m, 4H), 4.32-4.28 (m, 1H), 2.92-2.90 
(m, 1H), 2.51-2.47 (m, 2H), 1.06 (s, 9H); 13C NMR (62.5 MHz, CDCl3): δ 201.5, 137.3, 




















Metallacycles (2.2i) and (2.2j). The procedure analogous to that used for (2.1s) and 
(2.1t) afforded the reddish-brown solid residue as a 2:1 mixture of compounds 2.2i and 
2.2j (0.322 g, 88% combined yield from 2.2h on a 0.86 mmol scale). 1H NMR (250 MHz, 
C6D6): δ 7.92-7.88 (m, 6H), 7.32-7.28 (m, 4H), 6.20-6.40 (m, 1H), 5.88 (s, 5H), 5.87 (s, 
5H), 5.81 (s, 5H), 5.76 (s, 5H), 5.76-5.68 (m, 1H), 5.40-5.17 (m, 4H), 4.54-4.52 (m, 1H), 
3.92-3.89 (m, 1H), 3.64-3.60 (m, 1H), 3.36-3.27 (m, 1H), 2.90-2.86 (m, 1H), 2.76-2.68 
(m, 1H), 2.48-2.47 (m, 1H), 1.96-1.87 (m, 2H), 1.54-1.47 (m, 1H), 1.22-1.04 (m, 6H), 
1.33 (s, 9H), 0.95 (s, 9H); 13C NMR (75 MHz, C6D6): δ 142.5, 141.2, 138.0, 137.7, 136.5,  
131.2, 116.4, 115.8, 115.5, 115.3, 113.6, 85.2, 82.7, 77.9, 76.9, 69.7, 69.1, 67.8, 65.0, 





















hexahydrocyclopenta[b]furan-2-one (2.2k) and (3aR,4R,5S,6aS)-5-(tert-
butyldiphenylsilyloxy)-4-vinyl-hexahydrocyclopenta[b]furan-2-one (2.2l). The 
procedure analogous to that used for 2.1u and 2.1v afforded the clear oils 2.2k (0.089 g, 
39%) and 2.2l (0.071 g, 31%) in a 1.25:1 ratio from the metallacycles 2.2i and 2.2j on a 
0.70 mmol scale. Column chromatography (silica gel, hexanes/EtOAc, 90:10). Lactone 
2.2k: 1H NMR (250 MHz, CDCl3): δ 7.60-7.58 (m, 4H), 7.44-7.35 (m, 6H), 5.12-4.94 
(m, 1H), 5.12-4.94 (m, 3H), 4.41 (m, 1H), 3.04-2.94 (m, 1H), 2.77-2.26 (m, 2H), 2.15-
2.04 (m, 2H), 1.78-1.69 (m, 1H), 1.04 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 177.0, 
137.4, 137.3, 137.2, 135.6, 134.7, 131.4, 131.3, 129.3, 129.2, 119.0, 79.2, 57.4, 43.i9, 
43.8, 34.8, 28.5, 20.9, 0.9. Lactone 2.2l: 1H NMR (250 MHz, CDCl3): δ 7.65-7.62 (m, 
4H), 7.43-7.32 (m, 6H), 5.45-5.34 (m, 1H), 4.99-4.91 (m, 2H), 4.83-4.77 (m, 1H), 3.99-
3.92 (m, 1H), 2.75-2.67 (m, 1H), 2.59-2.45 (m, 3H), 2.02-1.97 (m, 2H), 1.02 (s, 9H); 13C 
NMR (62.5 MHz, CDCl3): δ 177.39, 137.8, 136.4, 136.3, 134.0, 133.7, 130.2, 128.0, 






2.3h 2.3i  
3-(tert-Butyldimethylsilyloxy)propanal (2.3i). The procedure analogous to that used for 
2.1f afforded the product 2.3i (8.71 g, 89% yield from the alcohol 2.3h on a 52.5 mmol 
scale) as a colorless oil. Column chromatography (silica gel, Pentane/ethyl ether, 95:05). 
1H NMR (300 MHz, CDCl3): δ 9.81-9.80 (d, J = 2.0 Hz, 1H), 4.01-3.97 (t, J = 12.0 Hz, 
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2H), 2.62-2.58 (m, 2H), 0.88 (s, 9H), 0.07 (s, 6H); 13C NMR (75 MHz, CDCl3): δ 203.6, 










1-(tert-Butyldimethylsilyloxy)-4-vinylhex-5-en-3-ol (2.3j). The procedure analogous to 
that used for 2.1l afforded the product 2.3j (5.00 g, 92% yield from the aldehyde 2.3i on a 
21.2 mmol scale) as a colorless oil. Column chromatography (silica gel, hexanes/EtOAc, 
95:05). 1H NMR (300 MHz, CDCl3): δ 5.98-5.82 (m, 2H), 5.19-5.10 (m, 4H), 3.93-3.80 
(m, 3H), 3.29 (br s, 1H), 2.87-2.80 (m, 1H), 1.75-1.64 (m, 2H), 0.92 (s, 9H), 0.09 (s, 6H); 








2.3b 2.3c  
Triphenylmethylium perchlorate (2.3c). Triphenylcarinol 2.3b (10 g, 38.4 mmol) was 
reacted with 70% HClO4 (12.92 mL) in 100 mL of acetic anhydride. The acid was added 
drop-wise from an addition funnel to the alcohol, which had been dissolved in the 
anhydride by gentle warming with a heat gun. The mixture was stirred rapidly with a 
magnetic stirrer and cooled in ice water during the addition to maintain the reaction 
temperature between 10 and 20 oC. After addition was complete, the mixture was stirred 
for an additional 1 h in the ice bath to assure complete precipitation of the product. The 
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stirring was ended, and the product was allowed to settle. The supernatant liquid was 
drawn off with a pipet, and the yellow solid was washed with 20 mL portions of 
anhydrous diethyl ether until the ether washing was colorless. After each washing, the 
ether was decanted. The remaining solid was then placed under high vacuum for 24 h to 
rid the solid of residual ether, acetic anhydride, and acetic acid. The product 2.3c (12.39 g 
91%) was stored in a light-tight flask under nitrogen atmosphere in the refrigerator as 










tert-Butyldimethyl(3-(trityloxy)-4-vinylhex-5-enyloxy)silane (2.3k). A solution of 2.3j 
(1.92 g, 7.5 mmol), 2.3c (8.00 g, 22.5 mmol) and DMAP (0.84 g, 7.5 mmol) in DCM (30 
mL) and 2,4,6-collidine (4.55 g, 37.5 mmol) was kept for 24 h at ambient temperature. 
Then ether (100 mL) was added and the precipitate that crushed out was filtered through 
Celite. The organic filtrate was washed with a saturated solution of CuSO4 (3 x 100 mL), 
dried with Na2SO4, filtered and concentrated under reduced pressure. Column 
chromatography (silica gel, hexanes/EtOAc, 97:03) yielded the purified product 2.3k 
(2.69 g, 72%) as a colorless oil. 1H NMR (300 MHz, CDCl3): δ 7.53-7.51 (m, 6H), 7.34-
7.25 (m, 9H), 6.05-5.82 (m, 2H), 5.18-4.85 (m, 4H), 3.52-3.42 (m. 2H), 3.37-3.29 (m, 
1H), 2.62-2.59 (m, 1H), 1.78-1.73 (m, 2H), 0.83 (s, 9H), -0.03 (s, 6H); 13C NMR (75 
MHz, C6D6): δ 147.1, 140.2, 139.1, 130.9, 129.3, 128.7, 118.5, 117.7, 88.4, 76.5, 62.3, 










3-(Trityloxy)-4-vinylhex-5-en-1-ol (2.3d). Into a 50 mL round-bottom flask was placed 
2.3k (2.0 g, 4.0 mmol) and THF (20 mL). To this stirred solution was added TBAF 
(4.81mL of 1.0 M solution in THF, 4.81 mmol). The solution was stirred for 4 h at room 
temperature before quenching the reaction with saturated ammonium chloride. The 
mixture was poured into a separatory funnel containing 10 mL of water and 10 mL of 
diethyl ether. The organic layer was extracted twice more with 10 mL portions of water. 
The combined aqueous layers were then back extracted with 20 mL of diethyl ether. The 
combined organic layers were washed with brine, dried over MgSO4, filtered and 
concentrated under reduced pressure. Column chromatography (silica gel, 
hexanes/EtOAc, 85:15) yielded the purified product 3.5a (1.30 g, 85%) as a colorless 
liquid. 1H NMR (250 MHz, CDCl3): δ 7.55-7.52 (m, 6H), 7.34-7.25 (m, 9H), 6.12-5.69 
(m, 2H), 5.18-4.84 (m, 4H), 3.52-3.45 (m, 3H), 2.71-2.68 (m, 1H), 1.77-1.67 (m, 2H); 
13C NMR (62.5 MHz, CDCl3): δ 145.5, 138.1, 137.7, 129.7, 128.1, 127.5, 117.3, 116.9, 
87.4, 75.1, 60.8, 51.5, 35.3. 
HO
PCC, NaOAc,




2.3d 2.3l  
3-(Trityloxy)-4-vinylhex-5-enal (2.3l).The procedure modified (NaOAc, equivalent in 
weight to PCC) to that used for 2.1f afforded the product 2.3l (0.23 g, 83% yield from the 
alcohol 2.3d on a 0.861 mmol scale) as a colorless oil. Column chromatography (silica 
gel, hexanes/EtOAc, 95:05). 1H NMR (250 MHz, CDCl3): δ 9.46-9.44 (m, 1H), 7.49-7.46 
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(m, 6H), 7.32-7.24 (m, 9H), 5.99-5.57 (m, 2H), 5.18-4.83 (m, 4H), 4.05-4.00 (m, 1H), 
2.68-2.60 (m, 1H), 2.45-2.29 (m, 2H); 13C NMR (62.5 MHz, CDCl3): δ 201.6, 144.9, 
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one (2.3o). The first part of this procedure is analogous to that used for 2.1s and 2.1t 
afforded metallacycles (0.58 g, 81% combined yield from the enal 2.3l on a 1.6 mmol 
scale) as a red solid. We then used the  red solid directly in the next step. The second 
procedure is analogous to that used for 2.1u and 2.1v afforded the white solids 2.3m 
(0.155 g, 37%), 2.3n and 2.3o (0.15 g, 37%) in a 2:1:1 ratio from the metallacycles 
mixture on a 1.3 mmol scale. Column chromatography (silica gel, hexanes/EtOAc, 
80:20). Lactone 2.3m: 1H NMR (250 MHz, CDCl3): δ 7.51-7.47 (m, 6H), 7.30-7.21 (m, 
9H), 5.48-5.30 (m, 1H), 4.98-4.82 (m, 3H), 3.99-3.96 (m, 1H), 2.73-2.47 (m, 3H), 2.08-
1.60 (m, 3H); 13C NMR (62.5 MHz, CDCl3): δ 171.6, 144.86, 138.4, 129.3, 128.3, 127.5, 
116.5, 88.2, 84.7, 80.3, 56.6, 42.0, 39.2, 35.5. Mixture of lactones 2.3n and 2.3o: 1H 
NMR (250 MHz, CDCl3): δ 7.47-7.43 (m, 12H), 7.30-7.25 (m, 18H), 6.18-6.04 (m, 1H), 
5.43-4.78 (m, 7H), 4.24-4.17 (m, 1H), 4.07-4.02 (m, 1H), 3.13-1.52 (m, 12H); 13C NMR 
(62.5 MHz, CDCl3): δ 177.6, 177.4, 144.8, 137.0, 135.3, 129.3, 129.2, 128.3, 127.7, 
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1-(tert-Butyldimethylsilyloxy)-4-vinylhex-5-en-3-yl methanesulfonate (2.5a). To a 
solution of 2.3j (5.0 g, 19.4 mmol) and Et3N (6.79 mL, 48.7 mmol) in DCM (50 mL) was 
added MsCl (3.34 g, 29.2 mmol) at 0 oC. The reaction mixture was stirred for 3 h, and 
ether added (50 mL). The precipitate formed was filtered through Celite and the filtrate 
was washed with a saturated solution of CuSO4 (2 x 50 mL). The combined organic 
layers were dried over MgSO4, filtered and concentrated in vacuo. Purification by column 
chromatography (silica gel, hexanes/EtOAc, 90:10) yielded the purified product 2.3k 
(5.21 g, 82%) as a colorless oil. 1H NMR (250 MHz, CDCl3): δ 5.84-5.68 (m, 2H), 5.21-
5.11 (m, 4H), 4.90-4.87 (m, 1H), 3.71-3.66 (m, 2H), 3.26-3.18 (m, 1H), 2.99 (s, 3H), 
1.88-1.79 (m, 2H), 0.86 (s, 9H), 0.03 (s, 6H); 13C NMR (62.5 MHz, CDCl3): δ 135.9, 







4-Vinylhex-5-en-1-ol (2.5b). To an ice-cooled and stirred suspension of LAH (1.57 g,  
41 mmol) in diethyl ether (50 mL) was added dropwise a solution of 2.5a (2.31 g, 6.9 
mmol) in diethyl ether (15 mL). This mixture was allowed to warm to room temperature 
and stirring was continued for 1.5 h. It was then cooled to 0 oC again, quenched with 
water, filtered through Celite and the filtrate was concentrated in vacuo. Purification by 
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column chromatography (silica gel, hexanes/EtOAc, 90:10) yielded the purified product 
2.5b (0.557 g, 64%) as a colorless oil. 1H NMR (250 MHz, CDCl3): δ 5.79-5.65 (m, 2H), 
5.06-4.99 (m, 4H), 3.68-3.61 (m, 2H), 2.74-2.68 (m, 1H), 1.63-1.46 (m, 4H); 13C NMR 









4-Vinylhex-5-enal (2.5c). The procedure analogous to that used for 2.1f afforded the 
product 2.5c (0.977 g, 61% yield from the alcohol 2.5b on a 12.9 mmol scale) as a 
colorless oil. Column chromatography (silica gel, pentane/ethyl ether, 90:10). 1H NMR 
(250 MHz, CDCl3): δ 9.78-9.77 (t, J = 1.1 Hz, 1H), 5.77-5.63 (m, 2H), 5.08-5.01 (m, 
4H), 2.78-2.69 (m, 1H), 2.50-2.44 (m, 2H), 1.80-1.71 (m, 2H); 13C NMR (62.5 MHz, 








2.5c 2.5d  
Metallacycle 2.5d. The procedure analogous to that used for metallacycles 2.1s and 2.1t 
afforded the sole product 2.5d (0.49 g, 87% yield from enal 2.5c on a 3.3 mmol scale) as 
a red solid. 1H NMR (250 MHz, CDCl3): δ 5.95 (s, 5H), 5.91 (s, 5H), 5.24-5.09 (m, 2H), 
5.05-4.97 (m, 1H), 3.39-3.32 (m, 1H), 2.89-2.81 (m, 1H), 2.56-2.51 (m, 1H), 1.93-1.86 
(m, 2H), 1.64-1.10 (m, 4H); 13C NMR (62.5 MHz, C6D6): δ 143.4, 114.2, 112.5, 85.7, 















2.5d 2.5e  
(3aR,4R,6aS)-4-vinyl-hexahydrocyclopenta[b]furan-2-one (2.5e). The procedure 
analogous to that used for lactones 2.1u and 2.1v afforded the sole product 2.5e (0.24 g, 
68% yield from metallacycle 2.5d on a 2.3 mmol scale) as an oil. Column 
chromatography was (silica gel, pentane/ethyl ether, 80:20). 1H NMR (250 MHz, 
CDCl3): δ 5.79-5.65 (m, 1H), 5.11-4.94 (m, 2H), 2.80-1.48 (m, 8H); 13C NMR (62.5 









(E)-Pent-2-en-4-yn-1-ol (2.6d). To a suspension of 2.6c (6.0 g, 124.9 mmol) in 100 mL 
of liquid ammonia was added slowly epichlorohydrin 2.6b (5.78 g, 62.4 mmol) as an 
ethereal solution. After stirring at -33 oC for 3 h, ether (100 mL) and ammonium chloride 
(10 mL) were added. The ammonia was allowed to evaporate and the aqueous phase was 
extracted with (2 x 30 mL) of ether. The combined extracts were dried over MgSO4, 
filtered and the ether removed in vacuo. Distillation (68-69 oC at 19 mm Hg yielded the 
purified product 2.6d (2.45 g, 48%) as a yellow liquid. 1H NMR (300 MHz, CDCl3): 
δ 6.44-6.35 (dt, J = 15.9 Hz, J = 4.9 Hz, 1H), 5.82-5.76 (d, J = 15.9 Hz, 1H), 4.27-4.19 












(E)-5-(Trimethylsilyl)pent-2-en-4-yn-1-ol (2.6d'). To a cooled (0 oC) THF solution of 
ethylmagnesium bromide (182 mL, 1.0 M solution in THF, 182 mmol) was added a 
solution of alcohol 2.6d (5 g, 60.9 mmol) in THF (50 mL). The suspension was stirred 
overnight at room temperature. The resulting solution was cooled to 0 oC and trimethyl 
silyl chloride (13.3 g, 121.8 mmol) was added dropwise. After complete addition, the 
mixture was heated to 50 oC for 2 h. After being cooled to 20 oC, 1N H2SO4 (20 mL) was 
cautiously added to the suspension. After stirring for 10 min, the reaction mixture was 
partitioned between ether and a saturated solution of NaHCO3. The organic layer was 
washed with brine, dried over Na2SO4, filtered and concentrated. The residue was 
purified by column chromatography (silica gel, hexanes/EtOAc, 80:20) yielded the 
purified product 2.6d' (8.55 g, 91%) as a colorless oil. 1H NMR (250 MHz, CDCl3): 
δ 6.31-6.21 (dt, J = 15.9 Hz, J = 5.0 Hz, 1H), 5.76-5.69 (d, J = 15.9 Hz, 1H), 4.16-4.14 
(m, 2H), 2.36 (br s, 1H), 0.16 (s, 9H); 13C NMR (62.5 MHz, CDCl3): δ 143.3, 110.6, 








(E)-(5-Bromopent-3-en-1-ynyl)trimethylsilane (2.6e). The alcohol 2.6d' (10 g, 64.8 
mmol) was dissolved in dry DCM (100 mL) and cooled to -30 oC under nitrogen. To this 
stirred solution was added triphenylphosphine (20.4 g, 77 mmol) followed by 
recrystallized NBS (13.8 g, 77 mmol). The reaction was run for 5 h after which the 
organic phase was washed with NaHCO3 (2 x 30 mL) and the organic layer was dried 
(MgSO4), filtered and concentrated. The crude was then treated with hexane (100 mL) 
which helped to precipitate out triphenylphosphine oxide and succinimide which were 
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filtered off. Column chromatography was dry-packed (silica gel, hexanes/EtOAc, 80:20) 
and yielded the purified product 2.6e (12.10 g, 86%) as a colorless oil. 1H NMR (250 
MHz, CDCl3): δ 6.36-6.24 (m, 1H), 5.78-5.72 (d, J = 15.5 Hz, 1H), 3.98-3.95 (m, 2H), 



















(2.6h'). The procedure analogous to that used for 2.1l afforded the diasteromeric products 
2.6h and 2.6h' in a 1:1 ratio (3.5 g, 79% yield from the aldehyde 2.3h on a 13.6 mmol 
scale) as a colorless oil. The diastereomers were not separable by column 
chromatography (silica gel, hexanes/EtOAc, 95:05). 1H NMR (250 MHz, CDCl3): δ 5.96-
5.82 (m, 2H), 5.47-5.36 (m, 2H), 5.27-5.19 (m, 2H), 3.94-3.81 (m, 6H), 3.45-3.23 (d, J = 
3.25 Hz, 1H), 3.20-3.15 (m, 2H), 3.04-3.02 (d, J = 3.65 Hz, 1H), 1.86-1.72 (m, 4H), 0.90 
(s, 18H), 0.18 (s, 18H), 0.08 (s, 12H); 13C NMR (62.5 MHz, CDCl3): δ 134.8, 134.4, 
117.8, 117.6, 104.6, 104.0, 90.4, 90.0, 74.0, 72.8, 62.5, 62.1, 44.3, 43.i9, 36.2, 35.9, 26.2, 

















Co-acetylene complexes 2.6i and 2.6i'. A mixture of 2.6h and 2.6h' (2.75 g 8.4 mmol) 
was added to a solution of Co2(CO)8 (3.4 g, 10.0 mmol) in DCM at 0 oC. This black-
reddish solution was stirred at room temperature for 2 h. The solvent was then removed 
under vacuo. The product diastereomers were in a 1:1 ratio, and not separable by column 
chromatography (silica gel, pentane/ethyl ether, 99:01) yielded the purified products 2.6i 
and 2.6i' (4.49 g, 94%) as a dark reddish oil. 1H NMR (250 MHz, CDCl3): δ 6.12-5.95 
(m, 1H), 5.82-5.65 (m, 1H), 5.22-5.08 (m, 4H), 4.09-3.67 (m, 7H), 3.59-3.42 (m, 1H), 
4.01-3.23 (m, 1H), 3.18 (s, 1H), 2.01-1.51 (m, 4H), 0.89 (s, 18H), 0.31 (s, 18H), 0.08 (s, 
12H); 13C NMR (62.5 MHz, CDCl3): δ 201.0, 138.8, 138.0, 118.0, 113.2, 77.5, 75.6, 

















Mesylated Co-acetylene complexes 2.6j and 2.6j'. The procedure analogous to that 
used for 2.5a afforded the products 2.6j and 2.6j' in an inseparable 1:1 mixture (4.87 g, 
86% yield from the alcohol mixture  2.6i and 2.6i' on a 8.7 mmol scale) as a dark reddish 
oil. Column chromatography (silica gel, pentane/ethyl ether, 95:05). 1H NMR (250 MHz, 
CDCl3): δ 5.91-5.70 (m, 2H), 5.39-5.23 (m, 4H), 5.03-4.93 (m, 2H), 4.17-4.11 (m, 2H), 
3.83-3.68 (m, 4H), 3.06 (s, 6H), 2.10-1.92 (m, 4H) 0.89 (s, 18H), 0.35 (s, 18H), 0.04 (s, 
12H); 13C NMR (62.5 MHz, CDCl3): δ 200.4, 137.9, 120.1, 119.3, 107.9, 107.2, 82.1, 
81.9, 80.6, 80.4, 59.4, 58.9, 54.8, 54.3, 53.7, 38.8, 38.7, 34.6, 32.9, 29.6, 26.3, 26.2, 18.7, 
18.5, 1.55, 1.33, -5.07, -5.15. 
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(3R,4S)-1-hydroxy-4-((trimethylsilyl)ethynyl)hex-5-en-3-yl methanesulfonate (2.6k) 
and (3R,4R)-1-hydroxy-4-((trimethylsilyl)ethynyl)hex-5-en-3-yl methanesulfonate 
(2.6k'). A solution of  2.6i and 2.6i' (1.23 g, 1.9 mmol) and ceric ammonium nitrate (4.18 
g, 7.6 mmol) in anhydrous methanol (30 mL) was stirred under nitrogen for 1 h. The 
reaction was quenched by addition of sat. NaCl solution. Extraction with DCM (2 x 30 
mL) drying with MgSO4, filtering and solvent removal afforded alcohol mixture  2.6k 
and 2.6k' as an inseparable 1:1 mixture (0.37 g, 68% yield) after column chromatography 
(silica gel, hexanes/EtOAc, 60:40). 1H NMR (250 MHz, CDCl3): δ 5.94-5.72 (m, 2H), 
5.54-5.27 (m, 4H), 4.98-4.88 (m, 2H), 3.81-3.77 (m, 4H), 3.65-3.58 (m, 2H), 3.12 (s, 
3H), 3.09 (s, 3H), 2.07-1.83 (m, 4H), 1.70-1.50 (m, 2H), 0.18 (s, 18H); 13C NMR (62.5 
MHz, CDCl3): δ 132.5, 132.2, 119.7, 102.3, 101.8, 91.8, 91.4, 80.3, 80.2, 58.4, 58.3, 








4-(Trimethylsilyl)ethynyl)hex-5-en-1-ol (2.6l). The procedure analogous to that used for 
2.5b afforded the product 2.6l (0.125 g, 62% yield from the alcohols 2.6k and 2.6k' on a 
1.03 mmol scale) as a colorless oil. Column chromatography (silica gel, pentane/ethyl 
ether, 90:10). 1H NMR (250 MHz, CDCl3): δ 5.83-5.69 (m, 1H), 5.35-5.08 (m, 2H), 3.71-
 74
3.66 (m, 2H), 3.17-3.09 (m, 1H), 1.81-1.52 (m, 4H), 1.35 (br s, 1H), 0.18 (s, 9H); 13C 








4-((Trimethylsilyl)ethynyl)hex-5-enal (2.6a). The procedure analogous to that used for 
2.1f afforded the product 2.6a (1.34 g, 74% yield from the alcohol 2.6l on a 9.3 mmol 
scale) as a colorless oil. Column chromatography (silica gel, pentane/ethyl ether, 90:10). 
1H NMR (250 MHz, CDCl3): δ 9.80 (s, 1H), 5.7-5.65 (m, 1H), 5.36-5.10 (m , 2H), 3.19-
3.16 (m ,1H), 2.61-2.55 (m, 2H), 1.95-1.90 (m, 2H), 0.16 (s, 9H); 13C NMR (62.5 MHz, 
CDCl3): δ 202.1, 137.0, 116.4, 106.1, 89.2, 41.4, 35.9, 27.5, 0.58.  
2.15.3 Spectral Data 
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PROGRESS TOWARD A CONVENIENT SYNTHESIS OF α-METHYLENE-γ-
BUTYROLACTONES FROM ALLENYL CARBONYL UNITS MEDIATED BY 
Cp2Ti(PMe3)2 THROUGH INTRAMOLECULAR CYCLOCARBONYLATION 
 
3.1 An Introduction to Allenes 
The simplest cumulated diene is 1,2-propadiene, CH2=C=CH2, also known as an 
allene. Indeed, cumulated dienes are often called allenes. In this present day, about 150 
natural products comprising of an allenic or cumulenic structure are known.3.1 A 
substantial number of these allenic natural products possess biological and 
pharmacological properties. Several compounds with an allenic moiety incorporated into 
the existing backbone of the molecule, have been developed and marketed (Figure 3.1), 
with the most noted example being enprostil,3.2 a PGE2-analogue that strongly inhibits 
gastric acid secretion.3.3 Enprostil is usually administered as a racemic mixture of 
diastereomers with regard to the allenic axis of chirality. The allenic PGF2α-analogues 




















































Scheme 3.1 Different Substitution Patterns of Allenes 
Allenes can be mono-, di-, tri- or tetra-substituted (Scheme 3.1). The central 
carbon of an allene is sp-hybridized and as a result, the double bond array is linear as a 
result. Since the π-bonds of allenes are orthogonal, an interesting consequence of this 
configuration is that allenes having two different substituents on each of the terminal 
carbon atoms are chiral. During the 1800’s, proving the existence of this class of 
compounds proved difficult.3.4 At the time, a lack of modern analytical techniques made 
it really difficult to distinguish allenes from the corresponding alkynes. However, with 
the introduction of IR and Raman Spectroscopy (allenes show a characteristic C-C 
vibration at about 1950 cm-1) and other sophisticated methods, it became possible to 
prove their existence irrefutably. Spurred by intent chemical curiosity, the chemistry of 
allenes has grown into an attractive and prolific area of interest. Reactions such as 
cycloadditions3.5 and electrocyclizations3.6 are among a few that have taken advantage of 
this versatile entity. In the field of transition metal catalysis, allenes have reemerged as 
highly interesting compounds in the past decade. Their slow rise from obscurity, as 
compared to the more popular alkenes and alkynes, is simply due to the increasing 
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Scheme 3.2 Selectivity Problems of Unsaturated Substrates 
As with alkynes, regio-, and stereoselectivity  issues are significant, but with allenes, we 
furthermore face the question of positional selectivity – which of the two orthogonal 
double bonds will react in the case of a single addition? 
3.2 Obtaining Cyclopentenones via Allenic Precursors 
In early investigations, reactions of allenes with transition metals proceeded quite 
unselectively and this led to the neglect of allenes as viable substrates. However, with the 
intramolecularization of reactions and other factors such as introducing substituents 
which impart steric hindrance and electronic differentiation, most of the positional 
selectivity problems were automatically solved. A key transition metal- 
mediated/catalyzed reaction where allenes have been used in place of olefins and 
produced cycloadduct products intramolecularly is the allenic Pauson-Khand reaction 
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Scheme 3.3 Positional Selectivity: Competing Pathways of the Allenic Pauson-
Khand Reaction 
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The Pauson-Khand reaction,3.8 or three component cyclopentenone synthesis 
(Scheme 3.4), has been used extensively in the synthesis of natural products.3.9 Dicobalt 
octacarbonyl, [Co2(CO) 8],3.10 is the most well-known and the most highly utilized 
reagent in the Pauson-Khand process. 
 
Scheme 3.4 General Pattern of the Pauson-Khand Reaction 
When alkynyl allenes are used as potential substrates for the intramolecular 
Pauson-Khand reaction as seen in Scheme 3.3, two different cycloadducts are produced 
(positional selectivity). If the external π-system of the allene reacts, then this affords the 
4-alkylidene cyclopentenone (B), and if the internal π-system of the allene reacts, then 
this route affords the α-methylene cyclopentenone (A). Either resulting cycloadduct gives 














15-Deoxy- Δ12, 14-PGJ2 Hydroxymethylacylfulvene
Crinipellin A  
Figure 3.2 Structures of 15-Deoxy-Δ12, 14-PGJ2, crinipellin A, and 
hydroxymethylacylfulvene 
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  The exo-α-methylene cyclopentenone is an especially exciting substitution pattern 
in synthesis and is often a major structural feature in the synthesis of biologically active 
natural products.  
There are a number of natural products that possess the α-methylene 
cyclopentenone moiety, including the prostaglandin 15-Deoxy-Δ12, 14-PGJ2. PGJ2 
represents the first natural ligand for any isoform of the peroxisome proliferators 
activated receptor (PPAR), which has been shown to be an active intermediate in diseases 
such as hypertension, obesity, non-insulin dependent diabetes mellitus (NIDDM) and 
coronary artery disease.3.12   
3.3 Allenic Pauson-Khand Reaction 
Cazes and co-workers have largely investigated the cobalt mediated 
intermolecular allenic Pauson-Khand reaction using dicobalt octacarbonyl and N-
methylmorpholine-N-Oxide (NMO) (Scheme 3.5).3.13 The reaction proceeds at very low 
temperatures (-78 oC to 20 oC) and occurs selectively with the less substituted π-bond of 
the allene. 
 
Scheme 3.5 Cazes’ Intermolecular Allenic Pauson-Khand Reaction 
Cazes and co-workers have also shown that medium rings can be formed in the 
intramolecular variant of the cobalt/NMO promoted allenic Pauson-Khand reaction 
(Scheme 3.6).3.13 These are the first reported examples of seven-membered rings formed 
via an intramolecular Pauson-Khand reaction. 
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Scheme 3.6 Cazes’ Intramolecular Allenic Pauson-Khand Reaction 
In these reactions, however, di- or trisubstituted allenes must be employed, because less 
substituted allenes tend to polymerize in the presence of Co2(CO)8.3.14   
Kay M. Brummond and co-workers have been at the forefront in extensively 
investigating the intermolecular allenic Pauson-Khand reaction. Her work has established 
the allenic Pauson-Khand reaction as the new and regioselective method for the 
preparation of α-methylene and 4-alkylidene cyclopentenones.3.15 The standard 
conditions used to effect the intramolecular allenic Pauson-Khand reactions are 
molybdenum hexacarbonyl [Mo(CO)6], dimethylsulfoxide (DMSO) and toluene at 100 
oC.3.15 Brummond’s work has yielded results which have ranged from obtaining the target 
compound stereoselectively in good yields, to obtaining the target compounds as 
mixtures. She has demonstrated that the formation of either the α-methylene or 4-
alkylidene cyclopentenone can be controlled by either the allene structure or reaction 
conditions.  
In the next four sections, a summary of Brummond’s work outlining the allenic 
Pauson-Khand reaction with different substitution patterns on the allenes will be 
reviewed.3.15 This overview will provide a helpful insight into our study which shares 
similar features such as positional selectivity of allenic substrates. 
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3.4 Cycloadditions of Monosubstituted Allenynes 
As shown in Table 3.1, all monosubstituted allenynes studied afforded the α-
methylene cyclopentenones as the only cycloadduct.  
Table 3.1 Cycloadditions of Monosubstituted Allenynes 
 
Possessing substituents on C4 and C5 of the tethers of the alkynyl allenes 3 and 5 
did not affect the outcome of the cyclization pathway. Also, lengthening the tether, as in 
alkynyl allene 7, still yielded the α-methylene cycloadduct, albeit in low yield. 
3.5 Cycloadditions of 1,3-Disubstituted Allenynes 
Next, Brummond and co-workers varied the substitution pattern on the allenes 
and explored the 1,3-disubstituted pattern (Table 3.2).  
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Table 3.2 Cycloadditions of 1,3-Disubstituted Allenynes 







3 4  E:Z 5:1
60%                 40%
1 2  E:Z 2:1
8
A                      75%
A                      70%
C                      62%
E                      48%
Conditions A: Mo(CO)6/DMSO/toluene/Ar/100 oC/10 h B: DMSO/air/CH2Cl2
40 oC/22 h C: Me3NO/CH2Cl2/Ar/1.3 h D: DMSO/air/benzene/40 oC/26 h




5                                  6                      7
E:Z 10:1










45%                 55%
E:Z 3.5:1
D                      33%
TMS
C7H15




These results indicate that the cycloaddition of 1,3-disubstituted allenynes 
generally affords mixtures of several possible cycloadducts. Different reaction conditions 
were studied and it appears that there is good control over the product ratio depending 
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upon the metal used (see entry 4 and 6). Essentially, contingent on the metal used, the 
regioselectivity can be directed to the internal π-bond (Path A in Scheme 3.3). 
3.6 Cycloadditions of 3,3-Disubstituted Allenynes 
Next, Brummond’s research group has shown that 3,3-disubstituted allenynes 
undergo cycloaddition with the least substituted π-bond of the allene and that the 
cycloaddition affords the bicyclo[4.3.0] nonane ring system (entries 1-3) and a 
bicyclo[3.3.0] octane ring system (entry 4), selectively (Table 3.3).  
Table 3.3 3,3-Disubstituted Allenynes 













Reaction Conditions: Mo(CO)6/DMSO/toluene/Ar/100 oC
















This result demonstrates a dependence of π-bond selectivity of the allenic [2+2+1] 
cycloaddition upon the substrate structures. To date, there are only a few examples of this 
type of substrate dependence in [2+2+1] cycloaddition reactions.3.16 
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3.7 Cycloadditions of Trisubstituted Allenynes 
Finally, Brummond and co-workers have shown that trisubstituted allenynes 
undergo cyclization exclusively with the less substituted π-bond of the allene as 
evidenced by entries 1 and 2 in Table 3.4. 
Table 3.4 Cycloadditions of Trisubstituted Allenynes 
 
Other groups have also shown that allenes can be used in these types of cycloadditions 
using catalytic cobalt and metals other than cobalt and molybdenum.3.17 
3.8 Goal of this Study 
At the initiation of our project, no examples using aldehydes in place of the 
alkyne component in the allenic Pauson-Khand reaction had been reported. We felt that it 
would be interesting to investigate the overall utility of this methodology by exploring 
the possibility of an allenic hetero Pauson-Khand reaction.  
In 1996, our research group discovered a new, titanium-mediated reaction which 
can be used for the synthesis of fused, bicyclic γ-butyrolactones from δ,ε-unsaturated 
carbonyls (Scheme 3.7).3.18  
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Scheme 3.7 General Hetero Pauson-Khand Reaction 
This reaction has since been termed the hetero Pauson-Khand (HPK) reaction and we 
have also since developed an asymmetric catalytic version of this reaction based on chiral 
ansa-bridged titanocene catalysts.3.19 A detailed review can be found in chapter 1 of this 
dissertation. Syntheses of new substrates play a very important role in the development of 
the hetero Pauson-Khand reaction. A variety of new substrates have been investigated, 
with the choice of a particular substrate often motivated by the desire to develop an 
efficient synthetic route to a particular class of natural products or to molecules which 
have potential to exhibit useful biological or medicinal properties. A brief survey of 
































X = H, Jasmonate synthesis









Scheme 3.8 Substrates under Investigation 
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This chapter adds allenyl aldehydes and allenyl ketones (section 3.13) to the list of new 
substrates studied by our group. 
3.9 Synthesis of α-Methylene-γ-Butyrolactones 
The structure of an α-methylene-γ-butyrolactone is not only an integral building 
block in organic synthesis, but can also be found in many natural compounds having 
biological activity. Sarkomycin, frullanolide and vernolepin are representative substances 
having the α-methylene-γ-butyrolactone structure. This moiety constitutes about 10 % of 













Figure 3.3 Biologically Active α-Methylene-γ-Butyrolactone Compounds 
Not only are α-methylene-γ-butyrolactones present in a large number of natural 
products, but the α-methylene-γ-butyrolactone unit is a good Michael acceptor and often 
plays a central role in biological activity. In our continued synthetic efforts to utilize the 
titanium-mediated cyclocarbonylation, we reasoned that the α-methylene-γ-butyrolactone 
moiety can be obtained from tethered allenyl aldehydes and allenyl ketones via path A 
under the established reaction conditions developed in our group (Scheme 3.9), while 










Scheme 3.9 Allenic Hetero-Pauson-Khand Reaction 
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While this project was underway, two procedures for the synthesis of cis-fused 
bicyclic α-methylene-γ-butyrolactones from allenyl carbonyl substrates were published 
independently by the Kang3.21 and Yu3.22 laboratories respectively. 
3.10 Ru-Catalyzed Cyclocarbonylation of Allenyl Carbonyls   
Kang and co-workers have utilized the late transition metal ruthenium in the form 
of Ru3(CO)12 and have demonstrated the catalytic ability of this late transition metal to 












n = 1, 2 X = NTs, O, C(CO2Et)2 R = H, CH3  
Scheme 3.10 Ru-Catalyzed [2+2+1] Cycloaddions of Allenyl Carbonyls 
The proposed mechanistic pathway for this catalytic process most likely involves  
first, a metallacyclopentene A,  followed by insertion of CO to form the carbonylated 
metallacycle B, and then finally reductive elimination to yield the bicyclic α-methylene-
γ-butyrolactone product (Scheme 3.11). The key active species in the catalysis is 
generally believed to be the unsaturated 16 electron complex, Ru(CO)4, which is 























Scheme 3.11 Proposed Mechanistic Route for Ru-Catalyzed [2+2+1] Cycloaddition 
of Allenyl Carbonyls 
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A table illustrating the results obtained from the ruthenium-catalyzed cyclocarbonylation 
of allenyl carbonyls is seen below in Table 3.5. The optimum reaction conditions for 
catalyzed cyclocarbonylation was found to be 1 mol % of Ru3(CO)12 in dioxane and 20 
atm of CO pressure at 120 oC for 12 h. This ruthenium cyclocarbonylation methodology 
was also found to be applicable to the conversion of ε-allenyl carbonyls into 
corresponding six-membered cis-fused α-methylene-γ-butyrolactone (Entry 2 and 5). 
Table 3.5 Ru-Catalyzed [2+2+1] Cycloadditions of Allenyl Carbonyls 
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3.11 Mo-Mediated Cyclocarbonylation of Allenyl Carbonyls 
More recently, Yu and co-workers also obtained α-methylene-γ-butyrolactones 
directly from allenyl carbonyls by utilizing stiochiometric amounts of Mo(CO)6 with 
DMSO (Table 3.6). The ideal reaction conditions for this system were determined to be 
1.2 equiv. of Mo(CO)6 and 10 equiv. of DMSO in toluene.3.22 
Table 3.6 Mo-Mediated Cyclocarbonylation of Allenyl Carbonyls 
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The plausible mechanistic pathway can be interpreted as follows: DMSO undergoes 
ligand exchange with CO on molybdenum and this results in a vacant orbital that can 
accommodate the allenic moiety and form A. Cyclization followed by migratory insertion 
of the vinyl group into the Mo-complex to yield C then undergoes reductive elimination, 






























Scheme 3.12 Possible Mo-Mediated Cyclocarbonylation Mechanism of Allenyl 
Carbonyls 
3.12 Research Aims  
The characteristic features of these recently established protocols emphasize the 
chemical efficiency of the three-component coupling process. This has encouraged us to 
keep carrying out our investigations in screening titanium metal-mediated 
cyclocarbonylations. This research endeavor will definitely provide further insight into 
expanding the scope and utility of these reactions. Ultimately, an underlying motive for 
this investigation is the eventual application of this method to natural product synthesis. 
Hence, described herein, are the results of our strategy aimed at adapting a practical 
titanium metal-mediated cyclocarbonylation to allenyl functionalitites. In the next 
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section, we will discuss the design and synthesis of six allenyl carbonyl substrates, where 
the substitution patterns are varied in an effort to observe the regiochemical outcome of 
the Cp2Ti(PMe3)2 mediated allenic Pauson-Khand reaction.  
3.13 Substrate Synthesis 
 In order to explore the range of allenyl carbonyls that may be cyclized via the 
titanium-mediated cyclocarbonylation reaction, we synthesized the desired allenyl 















Figure 3.4 Structures of Allenyl Carbonyls 3.1a-f 
13C NMR provides an excellent method for the structural analysis of allenes. In general, 
the central sp-hybridized carbon has a chemical shift of ca. 210 ppm and the terminal 
carbons have chemical shifts in the 75-100 ppm range, leading to a very distinctive 

















Figure 3.5 13C-NMR Chemical Shifts δ (ppm) of Simple Allenes 
 The terminal allenyl aldehyde 3.1a was synthesized by the cleavage of THF 
(3.2a) by t-butyldimethylsilyl iodide which was generated (in situ) by reaction of TBSCl  
 
Scheme 3.13 Synthesis of Iodide 3.3a 
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with NaI in MeCN to give the corresponding 4-iodobutanol 3.3a (Scheme 3.13).3.23 This 
regioselective reaction occured in high yield (91%) and required no purification. Our next 
objective was to obtain the allenic moiety. Standard methods of allene synthesis are based 
on the SN2′-type substitution of propargylic compounds (Scheme 3.14).3.24 
 
Scheme 3.14 SN2′-Type Substitution 
This led us to develop the organozinc reagent 3.3a′. This intermediate was generated 
from the iodide 3.3a using zinc dust in DMF.3.25 The zinc dust was then activated by the 
addition of some TMSCl; the mechanism of this activation is still unclear. The excess 
zinc dust was allowed to settle and the supernatant was then cannulated into a pre-mixed 































Scheme 3.15 Synthesis of Allene 3.4a 
Unfortunately, as evidenced by NMR, during subsequent chromatography, the 
starting material 3.3a was co-eluted with the product 3.4a and further separation was 
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necessary. We decided to react the mixture of starting iodide 3.3a and product allene 3.4a 
with excess NEt3 in DMF at 60 oC for 3 hours.3.26  
The iodide starting material 3.3a formed a quaternary ammonium salt and was 
easily trapped on silica gel during purification. However, this led to further loss of 
product allene 3.4a and our overall yield was unsatisfactory.  We then turned to a more 
efficient method of forming the organozinc intermediate 3.3a′.  
One of the most highly activated forms of zinc is known as Rieke zinc.3.27 We 
adopted this method and prepared the Rieke zinc by the reduction of ZnCl2 in THF with 
lithium naphtalenide. This reagent readily underwent oxidative addition with the iodide 
3.3a to yield the corresponding organozinc reagent 3.3a′. This procedure afforded the 



















Scheme 3.16 Synthesis of 3.4a via the Rieke Zinc Procedure 
Next, we used a HF solution in MeCN to cleave the silyl protecting group.3.28 This 
reaction was performed in a polyethylene flask. However, the yield of this reaction was 
low (47%), hence we switched to TBAF as the silyl deprotecting reagent (Scheme 3.17). 
PCC oxidation then furnished aldehyde 3.1a (Scheme 3.18). 
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Scheme 3.17 Synthesis of Allenic Alcohol 3.5a 
 
Scheme 3.18 Synthesis of Allenic Aldehyde 3.1a 
Allenyl ketone 3.1b was produced in a similar fashion to allenyl aldehyde 3.1a from 
cleavage of 2-methyl-tetrahydrofuran 3.2b (Scheme 3.19). The opening of 3.2b is highly 
regioselective, however, trace amounts of tert-butyl(4-iodopentyloxy)dimethylsilane3.28b 































Scheme 3.19 Synthesis of Allenic Ketone 3.1b 
In order to obtain the 3,3-disubstituted allenyl aldehyde 3.1c, alkylation of the 




Scheme 3.20 Synthesis of Alkyne 3.3c 
Unfortunately, this reaction yielded the desired product 3.3c as the minor product. We 
decided to follow a different procedure which utilizes NaNH2 as the base and DMPU as 
co-solvent. 3.30 This method afforded the desired product 3.3c in 82% yield (Scheme 
3.21). 
 
Scheme 3.21 Improved Synthesis of Alkyne 3.3c 
Product 3.3c was then treated with methylmagnesium bromide, CuBr and refluxed to 
produce 3.4c (71%) (Scheme 3.22).3.29 
 
Scheme 3.22 Synthesis of 3,3-Disubstituted Allene 3.4c 
The final aldehyde 3.1c was obtained by subsequent deprotection and oxidation steps 
(Scheme 3.23).  
 
Scheme 3.23 Synthesis of 3,3-Disubstituted Allenic Aldehyde 3.1c 
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Allenyl aldehyde 3.1d was obtained in a likewise fashion to compound 3.1c 
where phenylmagnesium bromide was used instead of methymagnesium bromide 
(Scheme 3.24).  
 
Scheme 3.24 Synthesis of 3,3-Disubstituted Allene 3.1d 
Both the methyl and phenyl substituents on products 3.1c and 3.1d will afford us the 
opportunity to study whether steric effects of substituents have an influence on the 
outcome of the titanium-mediated cyclocarbonylation. 
 The initial step to obtaining the1,3-disubstituted allenyl aldehyde 3.1e was by 
mesylation of 3-butyn-2-ol 3.2e,3.31 followed by a reaction with iodide 3.3a via the Rieke 
method to produce the 1,3-substituted allene 3.3e (Scheme 3.25). TBAF treatment 
 
Scheme 3.25 Synthesis of 1,3-Disubstituted Allene 3.3e 
and PCC oxidation provided the final product 3.1e (Scheme 3.26). Finally, allenyl 
aldehyde 3.1f was prepared. This compound possesses a tether that is one carbon 
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Scheme 3.26 Synthesis of 1,3-Disubstituted Allenic Aldehyde 3.1e 
shorter than the other allenyl carbonyls synthesized. It is speculated as to which of the π-
bonds of the allene will react during the reductive coupling step.  If the internal π-bond 
reacts, then 3.6f will be formed and if the external π-bond reacts, then 3.5f will be formed 
(Scheme 3.27). 
 
Scheme 3.27 Possible π-Bond Selectivity Products from Allenic Aldehyde 3.1f 
The synthesis of  compound 3.1f began with commercially available (3-
bromopropoxy)(tert-butyl)dimethylsilane, 3.2f and proceeded through the familiar 























Scheme 3.28 Synthesis of Allenic Aldehyde 3.1f 
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With the functionalized allenyl carbonyls 3.1a-f, in hand, we then pursued their use in the 
titanium-mediated Hetero Pauson-Khand reaction. 
3.14 Metallacycle Formation 
In our study of the reactions of the allenyl carbonyls 3.1a-f towards carbonylation, 
we first set out to isolate the initial reductive cyclization products. The first reductive 
cyclization reaction was run with allenyl aldehyde 3.1a with a stoichiometric amount of 
CpTi(PMe3)2 in pentane (Scheme 3.29). This resulted in very low yields of product 
formation. During the reaction, the formation of an insoluble by-product was also 
noticed. This prompted the need to carry out the reaction in other solvents. The next 
solvent tried was diethyl ether. The yield was higher but there was still insoluble by-
product present. Finally, the reaction was carried out in THF resulting in a dark reddish 


















Scheme 3.29 Synthesis of 3.6a 
Obtaining crystals of 3.6a via slow evaporation of THF was difficult but we were able 
obtain a few from the reaction of 3.1a in pentane. On the following page is an ORTEP 
representation confirming the presence of metallacycle 3.6a following a single crystal X-
ray structure determination (Figure 3.6). 
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Figure 3.6 ORTEP Plot of Metallacycle 3.6a 
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The other allenyl carbonyls 3.1b-f were also subjected to reductive coupling and the 
results of these reactions are summarized in Table 3.7. 






































Entry               Allenyl Carbonyl                         Metallacyclic Producta             Yieldb













All reactions were carried out with Cp2Ti(PMe3)2 (1.0 equiv.) for 2 h at room 
temperature in THF.(a) Chemical shifts of significant signals in ppm.
 (b) All yields are overall isolated yields starting from allenyl 



































The results shown in Table 3.7 indicate that in general, allenyl carbonyls undergo 
reductive coupling with Cp2Ti(PMe3)2. Entries 1 and 2 show that both allenic aldehydes 
and allenic ketones undergo reductive coupling on the substituted π-bond of the allenic 
moiety with ease. These findings are consistent with the selectivity pattern seen with 
ruthenium-catalyzed3.21 and molybdenum-mediated3.22 couplings earlier. Entry 3 indicates 
the preference of titanium-mediated reductive coupling on the more substituted π-bond of 
the allenic moiety. This selectivity is in direct contrast to the findings observed by 
Brummond and co-workers,3.17 where 3,3-disubstituted allenynes underwent 
cycloaddition on the least substituted π-bond of the allenic moiety (Table 3.3). Entry 5 
shows that titanium-mediated reductive coupling of 1,3-disubstituted allenyl carbonyls 
result in a mixture of two possible cycloadducts. However, further studies will have to be 
performed to determine how much the ratio of the two cycloadducts is changed when 
more sterically substituted substrates are employed. Finally, entries 4 and 6 indicate that 
possible metallacycles formed from the reductive cyclization of 3.1d and 3.1f 
decomposed into unidentifiable products. 13C NMR for both compounds show the 
existence of cyclopentadienyl carbons ranging from 114.4 ppm to 113.9 ppm and their 1H 
NMRs show the chemical shift signals characteristic for cyclopentadienyl protons in the 
range of 5.87 ppm to 5.67 ppm. It is likely that the bulkiness of the phenyl substituent in 
3.1d and the ring strain of the possible metallacycle 3.6f from allenyl aldehyde 3.1f lead 
to the decomposition observed. Chemical shifts of significant protons are denoted in 
Table 3.7. There is a clear pattern in the values of similar protons on the different 
metallacycles. Knowledge of these chemical shift values can aid in future assignment of 
such metallacycles. 
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3.15 Future Goals 
 The progress made in this titanium-mediated allenic hetero Pauson-Khand 
methodology is encouraging and informative. Further studies into reductive cyclization 
remain, in order to establish a general trend. Carbonylation studies are also currently 
underway to afford the desired α-methylene-γ-butyrolactones. 
3.16 Experimental Section 
3.16.1 General Methods 
All experiments were performed under a nitrogen or argon atmosphere in oven-dried 
glassware using a Vacuum Atmospheres dry box, or by using standard Schlenk 
techniques. Solvents used as reaction media were distilled immediately before use. Et2O 
pentane and THF were distilled from Na/benzophenone ketyl. CH2Cl2 was distilled from 
calcium hydride. Cp2Ti(PMe3)23.32 and PMe33.33 were prepared as described in literature.  
Other reagents were purified by simple distillation or by passing through a short column 
of activated alumna or silica gel. 1H and 13C NMR spectra were recorded on Bruker 250 
and 300 MHz spectrometers in deuterated solvents using the solvent carbon or residual 
protons (CHCl3: 7.27 ppm 1H, 77.23 ppm 13C, C6D6: 7.15 ppm 1H, 128.0 ppm 13C) as an 
internal reference unless otherwise stated. Chemical shifts (δ) are given in parts per 
million down from tetramethylsilane (TMS). Data for 1H NMR spectra are reported as 
follows: chemical shift (δ ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = 
quartet, quin = quintet, dd = doublet of doublets, qd = quartet of doublets, m = multiplet), 
coupling constant (Hz), and integration. 
 Analytical thin layer chromatography (TLC) was performed on Scientific 
Adsorbent Company Inc. silica gel plates. Components were visualized by illumination 
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with long wave ultraviolet light, exposure to iodine vapor, or by staining with p-
anisaldehyde in ethanol/sulfuric acid. Flash column chromatography was performed 
using silica gel (Scientific Adsorbent Company Inc. 32-63 μm particle size, 60 Å pore 
size). 
3.16.2 Preparative Procedures 
 
 tert-Butyl(4-iodobutoxy)dimethylsilane (3.3a). To a solution of TBSCl (10 g, 
66.34 mmol) in MeCN (150 mL) was added NaI (19.9 g, 132.69 mmol) and THF (17.5 
mL, 242.17 mmol). The reaction mixture was left to stir overnight at 60 ºC. After the 
reaction mixture was cooled to room temperature, it was poured into a separatory funnel 
containing water. The reaction mixture was extracted with pentane/ether (9 : 1, 3 x 500 
mL), and the combined organic layer was washed with saturated aqueous NaHCO3. After 
drying over MgSO4, the solvent was removed under reduced pressure. The product 3.3a 
(18.95 g, 91%). 3.3a must be foiled during storage to avoid light decomposition and was 
used in the next step without purification. 1H NMR (250 MHz, CDCl3): δ 3.63 (t, J = 6.2 
Hz, 2H), 3.22 (t, J = 7.0 Hz, 2H), 1.91 (m, 2H), 1.61 (m, 2H), 0.89 (s, 9H), 0.05 (s, 6H); 
13C NMR (62.5 MHz, CDCl3): δ 62.4, 33.9, 30.6, 26.3, 18.7, 7.6, -4.9. 
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tert-Butyl-hepta-5,6-dienyloxy-dimethyl-silane (3.4a). Procedure A: Zinc dust (10.8 g, 
47.7 mmol), was weighed into a 50 mL round-bottom flask with a side arm, which was 
repeatedly evacuated (with heating using a hot air gun) and flushed with nitrogen. Dry 
DMF (20 mL) and trimethylsilyl chloride (0.146 g, 0.975 mmol) were added, and the 
resultant mixture was stirred for 30 min at room temperature. The iodide 3.3a (5g, 15.9 
mmol)  was dissolved in dry DMF (20 mL) under nitrogen. The iodide solution was 
cannulated into the zinc suspenstion and stirred at 0 oC. After stirring for 2 h at 0 oC, the 
organozinc intermediate 3.3a′ was formed and the excess zinc dust was allowed to settle. 
The supernatant was cannulated under nitrogen to a pre-mixed solution of CuBr·SMe2 
(0.16 g, 5 mol%) and propargyl chloride (1.54 g, 20.7 mmol) in DMF (25 mL)  at -10 oC 
(ice-salt). The solution was then allowed to warm slowly to room temperature and stirred 
for a further 14 h. The reaction mixture was diluted with ethyl acetate (60 mL) and 
washed successively with water (40 mL), a saturated aqueous solution of CuSO4 solution 
(40 mL) and finally brine (40 mL). The combined organic extracts were dried with 
MgSO4, filtered and the solvent removed under reduced pressure. Unfortunately, this 
procedure yielded a mixture of product 3.4a and the starting iodide 3.3a which proved 
impossible to separate via chromatography.  
tert-Butyl-hepta-5,6-dienyloxy-dimethyl-silane (3.4a). Procedure B: Typical 
preparation of Rieke zinc: Finely cut lithium wire (99.9% pure, ~0.01% Na, 0.29 g, 42.5 
mmol) and naphthalene (2.04 g, 1.6 mmol) were weighed into a 100 mL, two-neck 
round-bottom flask equipped with an addition funnel. Similarly, in an argon drybox, 
ZnCl2 (2.79 g, 20.5 mmol) was weighed into a 50 mL round-bottom flask. The flasks 
were then transferred to the Schlenk line. THF (15 mL) was added to the flask with 
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lithium and naphthalene while ZnCl2 was dissolved in 20 mL of THF. After 1 h of 
stirring, the resulting dark green lithium napthalenide was ready. The dissolved THF 
solution of ZnCl2 was transferred via cannula into the addition funnel of the lithium 
napthalenide flask. Next, the THF solution of ZnCl2 was added dropwise into the lithium 
napthalenide taking care to maintain the green color. After the transfer was complete, the 
Rieke zinc was stirred for 30 min (to further ensure that all of the lithium was consumed) 
and the resulting black suspension of active zinc was allowed to settle. The supernatant 
was cannulated off and the remaining solvent was removed under vacuum. Iodide 3.3a (5 
g, 15.9 mmol) in 14 mL of dry DMF was added via syringe and stirred at 0 oC for 1 h 
before the excess zinc was allowed to settle. Once the organozinc intermediate 3.3a′ was 
generated, the supernatant was transferred carefully, under nitrogen via cannula into a 
pre-mixed solution of CuBr·SMe2 (0.16 g, 5 mol%) and propargyl chloride (1.54 g, 20.7 
mmol) in DMF (10 mL)  at -10 oC (ice-salt). The solution was then allowed to warm 
slowly to room temperature and stirred for a further 14 h. The reaction mixture was 
diluted with ethyl acetate (80 mL) and washed successively with water (60 mL), a 
saturated aqueous solution of CuSO4 solution (60 mL) and finally brine (60 mL). The 
combined organic extracts were dried with MgSO4, filtered and the solvent removed 
under reduced pressure. Column chromatography (silica gel, hexanes/EtOAc, 90:10) 
yielded the purified product 3.4a (2.3g, 60%) as a yellow oil. 1H NMR (250 MHz, 
CDCl3): δ 5.07 (quin, J = 6.7 Hz, 1H), 4.63 (m, 2H), 3.59 (t, J = 6.2 Hz, 2H), 2.00 (m, 
2H), 1.57-1.24 (m, 4H), 0.87 (s, 9H), 0.03 (s, 6H). 13C NMR (62.5 MHz, CDCl3): δ 
208.9, 90.4, 75.1, 63.4, 32.7, 28.4, 26.4, 25.8, 18.8, -4.9.  
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Hepta-5,6-dien-1-ol (3.5a). Procedure A: The TBS ether 3.4a (0.914 g, 4.03 mmol) was 
treated with 40 mL of 48% HF in acetonitrile (v/v 1/20) at room temperature for 2 h. 
Water was added (20 mL) and the mixture was extracted with CH2Cl2 (3 x 15 mL). The 
combined organic solutions were washed successively with water (15 mL) and brine (15 
mL), dried over MgSO4, filtered and concentrated under reduced pressure. Column 
chromatography (silica gel, hexanes/EtOAc, 80:20) yielded the purified product 3.5a 
(0.21g, 47%) as a colorless liquid.  
Hepta-5,6-dien-1-ol (3.5a). Procedure B: Into a 50 mL round-bottom flask was placed 
3.4a (0.914 g, 4.03 mmol) and THF (20 mL). To this stirred solution was added TBAF 
(4.84 mL of 1.0 M solution in THF, 4.84 mmol). The solution was stirred for 4 h at room 
temperature before quenching the reaction with saturated ammonium chloride. The 
mixture was poured into a separatory funnel containing 10 mL of water and 10 mL of 
diethyl ether. The organic layer was extracted twice more with 10 mL portions of water. 
The combined aqueous layers were then back extracted with 20 mL of diethyl ether. The 
combined organic layers were washed with brine, dried over MgSO4, filtered and 
concentrated under reduced pressure. Column chromatography (silica gel, 
hexanes/EtOAc, 80:20) yielded the purified product 3.5a (0.38 g, 84%) as a colorless 
liquid. 1H NMR (250 MHz, CDCl3): δ 5.11 (quin, J = 6.7, 1H), 4.66 (m, 2H), 3.67 (t, J = 
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6.3 Hz, 2H), 2.04 (m, 2H), 1.65-1.46 (m, 4H); 13C NMR (62.5 MHz, CDCl3): δ 208.9, 
90.1, 75.2, 63.2, 32.6, 28.3, 25.6. 
 
Hepta-5,6-dienal (3.1a). To a suspension of PCC (2 g, 9.48 mmol) in CH2Cl2 was added 
neutral Al2O3 (2 g) at room temperature. After 30 min stirring, the alcohol 3.5a (0.532 g, 
4.74 mmol) was added, and then further stirring for 2 h during which time the reaction 
mixture turned dark brown in color. The reaction mixture was diluted with ether and 
filtered through a plug of dry silica gel. The solvent was evaporated under reduced 
pressure. Purification by column chromatography (silica gel, pentane/ethyl ether, 95:05) 
yielded the product 3.1a (0.428 g, 82%) as a colorless liquid. 1H NMR (250 MHz, 
CDCl3): δ 9.75 (t, J = 1.7 Hz, 1H), 5.05 (quin, J = 6.7 Hz, 1H), 4.66 (m, 2H), 2.46 (m, 
2H), 2.03 (m, 2H), 1.74 (m, 2H); 13C NMR (62.5 MHz, CDCl3): δ 209.1, 202.9, 89.4, 











tert-Butyl(5-iodopentan-2-yloxy)dimethylsilane (3.3b). 3.3b was prepared on a 66.34 
mmol scale using the procedure described above for 3.3a and utilizing 3.2b. Column 
chromatography (silica gel, 100% hexanes) yielded 3.3b (18.6 g, 85%) as a yellow liquid. 
1H NMR (250 MHz, CDCl3): δ 3.81 (m, 1H), 3.20 (t, J = 7.0 Hz, 2H), 1.89 (m, 2H), 1.52 
(m, 2H), 1.13 (d, J = 6.0 Hz, 3H), 0.87 (s, 9H), 0.05 (s, 6H); 13C NMR (62.5 MHz, 
CDCl3): δ 67.9, 40.7, 30.3, 26.2, 24.2, 18.4, 7.6, -4.3. (A trace amount of tert-butyl(4-












tert-Butyldimethyl(octa-6,7-dien-2-yloxy)silane (3.4b). The procedure analogous to 
that used for 3.4a (Procedure B) afforded the product 3.4b (2.5 g, 65% yield from the 
iodide 3.3b on a 15.9 mmol scale) as a colorless oil. Column chromatography (silica gel, 
hexanes/EtOAc, 98:02). 1H NMR (300 MHz, CDCl3): δ 5.10 (quin, J = 6.7 Hz, 1H), 4.67 
(m, 2H), 3.80 (q, J = 5.5 Hz, 1H), 2.00 (m, 2H), 1.17-1.40 (m, 4H), 1.13 (d, J = 6.1 Hz, 
3H), 0.87 (s, 9H), 0.05 (s, 6H); 13C NMR (62.5 MHz, CDCl3): δ 208.9, 90.4, 75.0, 68.6, 
39.5, 28.6, 26.3, 25.7, 24.2, 18.5, -4.3. 
 
Octa-6,7-dien-2-ol (3.5b). The procedure analogous to that used for 3.5a (Procedure B) 
afforded the product 3.5b (1.2 g, 84% yield from the TBS ether 3.4b on a 11.5 mmol 
scale) as a colorless oil. Column chromatography (silica gel, hexanes/EtOAc, 80:20). 
1H NMR (300 MHz, CDCl3): δ 5.13 (quin, J = 6.7 Hz, 1H), 4.70 (m, 2H), 3.85 (q, J = 5.6 
Hz, 1H), 2.06 (m, 2H), 1.55-1.49 (m, 4H), 1.24 (d, J = 6.2 Hz, 3H); 13C NMR (62.5 MHz, 
CDCl3): δ 208.9, 96.1, 75.2, 68.3, 39.0, 28.5, 25.6, 23.9. 
 
Octa-6,7-dien-2-one (3.1b). The procedure analogous to that used for 3.1a afforded the 
product 3.1b (0.75 g, 69% yield from the alcohol 3.5b on a 8.79 mmol scale) as a 
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colorless oil. Column chromatography (silica gel, pentane/ethyl ether 95:05). 1H NMR 
(300 MHz, CDCl3): δ 5.07 (quin, J = 6.7 Hz, 1H), 4.68 (m, 2H), 2.48 (m, 2H), 2.14 (s, 
3H), 2.01 (m, 2H), 1.71 (m, 2H); 13C NMR (62.5 MHz, CDCl3): δ 209.1, 206.3, 89.9, 
75.2, 41.8, 29.5, 28.0, 23.5. 
 
tert-Butyl(7-methoxyhep-5-ynyloxy)dimethysilane (3.3c). Procedure A: BuLi (33.7 mL 
of 2.0 M solution in hexanes, 69.4 mmol) was added over 40 min to a solution of methyl 
propargyl ether 3.2c (5 g, 71.3 mmol) in 200 mL of anhydrous THF at 0 oC. The TBS 
ether of 4-iodobutanol 3.3a (11.2 g, 35.6 mmol) was added via syringe over 5 min. The 
reaction mixture was heated at reflux for 4 days, cooled to room temperature, and 
quenched by the addition of 100 mL of water. Most of the THF was removed under 
reduced pressure and the residue was extracted with 5 x 50 mL of ether. The combined 
organic extracts were dried over MgSO4, filtered and concentrated under reduced 
pressure. Purification by column chromatography (silica gel, hexanes/EtOAc, 90/10) 
yielded the product 3.3c (1.34 g, 15%) as a yellow oil. 
tert-Butyl(7-methoxyhep-5-ynyloxy)dimethysilane (3.3c). Procedure B: Into a 100 mL 
round-bottom flask sodium amide (1.65 g, 42.3 mmol) was added and the powder 
suspended in 30 mL of THF. The flask was cooled to -78 oC and methyl propargyl ether  
3.2c (2.30 g, 32.8 mmol) was added, via syringe, as a solution in THF. The suspension 
was stirred at -78 oC for 1 h and then warmed to room temperature for 1 h to ensure 
formation of the acetylide. The suspension was cooled to -78 oC and 7.54 mL (62.3 
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mmol) of DMPU was added. 12.3 g, (39 mmol) of iodide 3.3a, was added via syringe, as 
a solution in THF and the reaction was allowed to warm up to room temperature. After 
12 h, the reaction was quenched with saturated ammonium chloride and the mixture 
poured into a separatory funnel containing 80 mL of water and 80 mL of diethyl ether. 
The organic portion was extracted twice more with 50 mL portions of water and the 
combined aqueous layers back extracted with 100 mL of diethyl ether. The combined 
organic layers were washed with brine, dried over MgSO4, filtered and concentrated 
under reduced pressure. The crude residue was purified by column chromatography 
(silica gel, hexanes/EtOAc, 90/10) to yield 3.3c (7.3 g, 82%) as a clear colorless liquid. 
1H NMR (300 MHz, CDCl3): δ 4.07 (t, J = 2.1 Hz, 2H), 3.62  (t, J = 5.9 Hz, 2H), 3.36 (s, 
3H), 2.26 (m, 2H), 1.60 (m, 4H), 0.89 (s, 9H), 0.04 (s, 6H); 13C NMR (75 MHz, CDCl3): 







3.3c 3.4c  
tert-Butyldimethyl(5-methylhepta-5,6-dienyloxy)silane (3.4c). Methylmagnesium 
bromide (7.8 mL of 3.0 M solution in ether, 23.3 mmol) was added to a solution of 3.3c 
(3.0 g, 11.7 mmol) and CuBr (0.5 g, 3.5 mmol) in 100 mL of anhydrous ether. The 
resulting black solution was heated at reflux for 60 h. The reaction was cooled, quenched 
with water, and the mixture transferred into separatory flask. The product was extracted 
with ethyl ether (3 x 50 mL). The combined extracts were dried over MgSO4, filtered and 
concentrated under reduced pressure. Column chromatography (silica gel, 
hexanes/EtOAc, 90:10) yielded the purified product 3.4c (1.86 g, 71%) as a colorless 
liquid. 1H NMR (300 MHz, CDCl3): δ 4.59 (m, 2H), 3.64 (m, 2H), 1.95 (m, 2H), 1.67 (m, 
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3H), 1.57-1.47 (m, 4H), 0.90 (s, 9H), 0.05 (s, 6H); 13C NMR (75 MHz, CDCl3): δ 207.7, 
99.8, 75.4, 64.6, 34.7, 33.9, 27.5, 25.2, 20.2, 19.9, -3.7. 
 
5-Methylhepta-5,6-dien-1-ol (3.5c). The procedure analogous to that used for 3.5a 
(Procedure B) afforded the product 3.5c (0.52 g, 86% yield from the TBS ether 3.4c on a 
4.7 mmol scale) as a colorless oil. Column chromatography (silica gel, hexanes/EtOAc, 
80:20). 1H NMR (300 MHz, CDCl3): δ 4.60 (m, 2H), 3.66 (t, J = 6.2 Hz, 2H),1.97 (m, 
2H), 1.68 (m, 3H), 1.61-1.50 (m, 4H), 0.05 (s, 6H); 13C NMR (62.5 MHz, CDCl3): δ 








5-Methylhepta-5,6-dienal (3.1c). The procedure analogous to that used for 3.1a afforded 
the product 3.1c (0.41 g, 85% yield from the alcohol 3.5c on a 3.96 mmol scale) as a 
colorless oil. Column chromatography (silica gel, pentane/ethyl ether, 95:05). 1H NMR 
(300 MHz, CDCl3): δ 9.77 (s, 1H), 4.62 (m, 2H), 2.45 (m, 2H), 1.97 (m, 2H), 1.79 (m, 
2H), 1.68 (m, 3H); 13C NMR (62.5 MHz, CDCl3): δ 206.5, 202.9, 97.8, 74.9, 43.7, 33.0, 
20.2, 19.0. 
 
Butyldimethyl(5-phenylhepta-5,6-dienyloxy)silane (3.4d). The procedure analogous to 
that used for 3.4c utilizing phenylmagnesium bromide afforded the product 3.4d (3.8 g, 
89% yield from 3.3c on a 14 mmol scale) as a colorless oil. Column chromatography 
(silica gel, hexanes/EtOAc, 90:10). 1H NMR (300 MHz, CDCl3): δ 7.46-7.23 (m, 5H), 
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5.11 (m, 2H), 3.66 (m, 2H), 2.47 (m, 2H), 1.67-1.60 (m, 4H), 0.90 (s, 9H), 0.09 (s, 6H); 
13C NMR (75 MHz, CDCl3): δ 210.2, 138.0, 129.9, 128.1, 127.5, 106.5, 79.7, 64.6, 34.1, 
30.8, 27.5, 25.7, 19.9, -3.6. 
 
5-Phenylhepta-5,6-dien-1-ol (3.5d). The procedure analogous to that used for 3.5a 
(Procedure B) afforded the product 3.5d (1.5 g, 71% yield from the TBS ether 3.4d on a 
11.3 mmol scale) as a colorless oil. Column chromatography (silica gel, hexanes/EtOAc, 
80:20). 1H NMR (300 MHz, CDCl3): δ  7.46-7.22 (m, 5H), 5.12 (m, 2H), 3.72 (m, 2H), 
2.15 (m, 2H), 1.74-1.65 (m, 4H); 13C NMR (62.5 MHz, CDCl3): δ 208.9, 136.7, 128.8, 
127.7, 126.8, 105.2, 78.7, 63.0, 32.7, 29.5, 25.3. 
 
5-Phenylhepta-5,6-dienal (3.1d). The procedure analogous to that used for 3.1a afforded 
the product 3.1d (0.9 g, 59% yield from the alcohol 3.5d on a 8.17 mmol scale) as a 
colorless oil. Column chromatography (silica gel, Pentane/ethyl ether, 95:05). 1H NMR 
(300 MHz, CDCl3): δ 9.79 (s, 1H), 7.42-7.26 (m, 5H), 5.11 (m, 2H), 2.55-2.49 (m, 4H), 
1.94 (m, 2H); 13C NMR (75 MHz, CDCl3): δ 210.1, 203.9, 137.5, 130.0, 128.4, 127.5, 
105.7, 80.3, 44.9, 30.3, 21.8. 
 
But-3-yn-2-yl methanesulfonate (3.2e′). Methanesulfonyl chloride (8.28 mL, 107 
mmol) was added dropwise at 0 oC to a solution of but-3-yn-2-ol 3.2e, (5 g, 71 mmol) in 
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CH2Cl2 (150 mL), containing NEt3 (24.85 mL, 178 mmol). The reaction was over within 
2 h, as determined by TLC; the mixture was then allowed to warm to room temperature, 
and diethyl ether (100 mL) and water (50 mL) were added. The aqueous phase was 
extracted twice with 100 mL of diethyl ether; the combined organic phases were washed 
copiously with a saturated aqueous solution of CuSO4 and finally, brine. The combined 
organic phase was dried over MgSO4, filtered and concentrated under reduced pressure. 
Column chromatography (silica gel, hexanes/EtOAc, 95:05) yielded the purified product 
3.2e′ (8.76 g, 83%) as a yellow oil. 1H NMR (300 MHz, CDCl3): δ 5.29 (qd, J = 6.7 Hz, J 
= 2.1 Hz, 1H), 3.13 (s, 3H), 2.71 (d, J = 2.0 Hz, 1H), 1.68 (d, J = 6.7 Hz, 3H); 13C NMR 
(75 MHz, CDCl3): δ 81.7, 77.9, 69.0, 40.6, 23.9. 
 
tert-Butyldimethyl(octa-5,6-dienyloxy)silane (3.3e). The procedure analogous to that 
used for 3.4a (Procedure B) utilizing 3.2e′ afforded the product 3.3e (2.7 g, 71% yield 
from the iodide 3.3a on a 15.9 mmol scale) as a colorless oil. Column chromatography 
(silica gel, hexanes/EtOAc, 98:02). 1H NMR (300 MHz, CDCl3): δ 5.08 (m, 2H), 3.65 (t, 
J = 6.3 Hz, 2H), 2.20 (m, 2H), 1.68 (m, 3H), 1.62-1.44 (m, 4H), 0.93 (s, 9H), 0.08 (s, 




Octa-5,6-dien-1-ol (3.4e). The procedure analogous to that used for 3.5a (Procedure B) 
afforded the product 3.4e (0.42 g, 67% yield from the TBS ether 3.3e on a 4.99 mmol 
scale) as an oil. Column chromatography (silica gel, hexanes/EtOAc, 80:20). 1H NMR 
(300 MHz, CDCl3): δ 5.08 (m, 2H), 3.66 (m, 2H), 2.02 (m, 2H), 1.64 (m, 3H) 1.60-1.48 
(m, 4H); 13C NMR (75 MHz, CDCl3): δ 206.3, 91.5, 87.2, 64.2, 33.6, 30.1, 26.7, 16.1. 
 
Octa-5,6-dienal (3.1e). The procedure analogous to that used for 3.1a afforded the 
product 3.1e (0.3 g, 73% yield from the alcohol 3.4e on a 3.33 mmol scale) as a colorless 
oil. Column chromatography (silica gel, pentane/ethyl ether, 95:05). 1H NMR (300 MHz, 
CDCl3): δ 9.78 (s, 1H), 5.05 (m, 2H), 2.47 (m, 2H), 2.02 (m, 2H), 1.75 (m, 2H), 1.65 (dd, 
J = 6.8 Hz, J = 3.3 Hz, 3H); 13C NMR (62.5 MHz, CDCl3): δ 206.2, 202.8, 90.0, 86.3, 










tert-Butyl(hexa-4,5-dienyloxy)dimethylsilane (3.3f). The procedure analogous to that 
used for 3.4a (Procedure B) utilizing 3.2f afforded the product 3.3f (2.6 g, 77% yield 
from the bromide 3.2f on a 15.9 mmol scale) as a colorless oil. Column chromatography 
(silica gel, hexanes/EtOAc, 98:02). 1H NMR (300 MHz, CDCl3): δ 5.12 (quin, J = 6.7 
Hz, 1H), 4.65 (m, 2H), 3.63 (t, J = 4.0, 2H), 2.07 (m, 2H), 1.67 (m, 2H), 0.90 (s, 9H), 




Hexa-4,5-dien-1-ol (3.4f). The procedure analogous to that used for 3.5a (Procedure B) 
afforded the product 3.5f (0.5 g, 67% yield from the TBS ether 3.4f on a 7.72 mmol 
scale) as a colorless oil. Column chromatography (silica gel, hexanes/EtOAc, 80:20). 1H 
NMR (300 MHz, CDCl3): δ 5.13 (quin, J = 6.7 Hz, 1H), 4.69 (m, 2H), 3.71 (q, J = 6.0 
Hz, 2H), 2.11 (m, 2H), 1.70 (m, 2H); 13C NMR (62.5 MHz, CDCl3): δ 208.9, 89.8, 75.5, 
62.6, 32.2, 24.8. 
 
Hexa-4,5-dienal (3.1f). The procedure analogous to that used for 3.1a afforded the 
product 3.1f (0.31 g, 74% yield from the alcohol 3.4f on a 4.36 mmol scale) as a colorless 
oil. Column chromatography (silica gel, pentane/ethyl ether, 95:05). 1H NMR (300 MHz, 
CDCl3): δ 9.80 (s, 1H), 5.20 (m, 1H), 4.74 (m, 2H), 2.59 (m, 2H), 2.34 (m, 2H); 13C 
NMR (75 MHz, CDCl3): δ 210.0, 203.4, 90.2, 78.1, 43.9, 22.1. 
 
Metallacycle (3.6a). To a solution of Cp2Ti(PMe3)2 (0.209 g, 0.63 mmol) in THF (5 mL) 
was added aldehyde 3.1a (0.07 g, 0.63 mmol) inside an argon filled glove box. After 
stirring for 2 h at room temperature, the reaction mixture was filtered through a pad of 
Celite and rinsed with pentane to give a reddish-brown solution. THF was removed under 
reduced pressure and the reddish-brown solid residue was obtained as the titled 
compound 3.6a (0.172 g, 94%). 1H NMR (300 MHz, C6D6): δ 5.97 (s, 5H), 5.89 (s, 5H), 
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5.71 (s, 1H), 5.03 (m, 1H), 4.15 (m, 1H), 3.78-3.71 (m, 1H), 2.22-2.15 (m, 2H), 1.94-1.84 
(m, 2H), 1.53-1.35 (m, 2H); 13C NMR (62.5 MHz, C6D6): δ 204.2, 115.9, 115.1, 114.1, 
85.5, 79.1, 37.5, 36.1, 24.8. 
 
Metallacycle (3.6b). The procedure analogous to that used for 3.6a afforded the product 
3.6b (0.155 g, 89% yield from the aldehyde 3.1b on a 0.57 mmol scale) as a reddish-
brown solid. 1H NMR (300 MHz, C6D6): δ 5.96 (s, 5H), 5.95 (s, 5H), 5.74 (s, 1H), 4.21 
(s, 1H), 3.93-3.89 (m, 1H), 2.20-1.35 (m, 6H), 1.29 (s, 3H); 13C NMR (62.5 MHz, C6D6): 
δ 203.9, 115.6, 115.1, 114.6, 94.2, 81.9, 42.8, 34.6, 27.8, 24.7. 
 
Metallacycle (3.6c). The procedure analogous to that used for 3.6a afforded the product 
3.6c (0.148 g, 85% yield from the aldehyde 3.1c on a 0.57 mmol scale) as a reddish-
brown solid. 1H NMR (250 MHz, C6D6): δ 6.09 (s, 5H), 5.98 (s, 5H), 5.84 (s, 1H), 4.09 
(s, 1H), 4.82 (m, 1H), 1.71-1.47 (m, 6H), 1.26 (s, 3H); 13C NMR (62.5 MHz, C6D6): δ 



















Mixture of metallacycles (3.5e) and (3.6e). The procedure analogous to that used for 
3.6a afforded the mixture of products 3.5e and 3.6e in a 4:1 ratio (0.14 g, 80% yield from 
the aldehyde 3.1e on a 0.58 mmol scale) as a reddish-brown solid. Major product 3.5e: 1H 
NMR (300 MHz, C6D6): δ 6.11 (s, 5H), 6.02 (s, 5H), 5.22 (m, 1H), 4.29 (m, 1H), 3.89 
(m, 1H), 2.18-1.35 (m, 6H), 1.74 (d, J = 6.4, 3H); 13C NMR (75 MHz, C6D6): δ 191.5, 
124.9, 116.2, 115.4, 86.2, 76.1, 38.5, 34.9, 26.2, 17.7. Minor product 3.6e: 1H NMR (300 
MHz, C6D6): δ 6.18 (s, 5H), 6.08 (s, 5H), 5.96 (m, 1H), 5.15 (m, 1H), 3.70 (m, 1H), 1.66-
1.35 (m, 6H), 1.22 (d, J = 6.4, 3H); 13C NMR (75 MHz, C6D6): δ 192.4, 124.0, 115.5, 
114.4, 85.6, 80.9, 38.7, 37.6, 25.7, 20.7. 
3.16.3 Spectral Data 
Spectral data for the experimental details discussed above are shown on the next page. 
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AN APPROACH TO THE FORMATION OF THE PYRROLIZIDINE AND 
INDOLIZIDINE ALKALOID SKELETONS VIA TITANIUM 
CATALYZED/MEDIATED SYNTHESIS 
 
4.1 Introduction to Alkaloids 
Synthetic chemists have always marveled at Nature’s ability to elaborate a 
fantastic variety of structurally diverse and frequently very complex substances from a 
few relatively simple starting materials. Alkaloids, derived from plants or animals, are the 
picture perfect model of this phenomenon. The term alkaloid was originally coined by 
Meissner in 1818 to cover alkali-like compounds that contain nitrogen either in a 
heterocyclic ring or as part of an acyclic chain. Many alkaloids are not, however, notably 
basic in character and certain nitrogen containing heterocyclic compounds, such the 
purines and pyrimidines in DNA and RNA, are not considered to be alkaloids. 
Medicinally, the alkaloids have played a key role for milennia, and even today some 25% 
of commercial drugs are either alkaloids or their structural modifications or analogues.  
At present, some 6000 natural alkaloids are known.4.1 These can be subdivided 
according to their chemical structures. Typical structural groups are indole alkaloids (e.g. 
reserpine, which possesses blood pressure reducing properties), pyrrolidine alkaloids (e.g. 
mesembrine, a potent serotonin uptake inhibitor), tropane alkaloids (cocaine and its 
relatives, such as atropine and scopolamine; these are anticholinergic agents), quinoline 
alkaloids (the malaria drug quinine and morphine for pain relief and the izidine alkaloids 
(securinine, a CNS stimulant, is an indolizidine). Also pilocarpine, a histidine derivative 
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which is used for the treatment of glaucoma, belongs to this broad class of natural 
products (Figure 4.1).  
 
Figure 4.1 Various Structural Alkaloids 
We are currently directing our interest at the alkaloid family known as izidine 
alkaloids. These alkaloids include some 500 compounds containing a pyrrolizidine, 
indolizidine or quinolizidine skeleton (Figure 4.2).  
 
Figure 4.2 Different Izidine Alkaloid Skeletons 
Several of them have interesting physiological and pharmacological activities. Stirring 
further interest, some compounds in this class also bear a close resemblance to the amino 
sugars.4.1   
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4.2 Research Focus 
We shall now further pinpoint our focus on pyrrolizidines and indolizidines. The 
syntheses of pyrrolizidines have been reviewed.4.2 Although many of these compounds 
occur as mono or bisesters or lactones, the vast majority of efforts have been expended on 
devising ways to assemble the core necine bases also called 1-
hydroxymethylpyrrolizidines with control of the extent and stereochemistry of 
oxygenation about the ring. The highlight in this very broad area must be the ongoing 
contribution made by Denmark and his group.4.3 
As with the pyrrolizidines, interest in the indolizidines has led to a wide array of 
new synthetic methodology being developed, but the more useful biological activity 
profile of certain members of this class has tended to focus efforts, and a host of 
syntheses of certain individual compounds have been recorded. For example, there have 
been at least 20 syntheses of monomorine in both racemic and enantiomerically pure 
forms, but those by Livinghouse4.4 and Mori4.5 are amongst the most interesting.  
Hence, in view of their potent and various biological activities,4.6-7 pyrrolizidine 
and indolizidine alkaloids as well as structurally related unnatural compounds are 
continuously stimulating new synthetic approaches. An exhaustive coverage of the 
literature dealing with pyrrolizidine and indolizidines is currently assured by specialist 
periodicals.4.8-9  
4.3 Metathesis 
Our interest in the diverse applications of these structurally intricate ring systems 
has propelled us into investigating two proposed ideas. The first concept describes a short 
and versatile synthesis of indolizidine tailored derivatives, in a process, which constitutes 
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the first performance of metathsis reactions of the complex [Cp2Ti=CH2] with imino-
alkyne substrates starting from Cp2TiMe2.4.10 The blossoming field of metathesis, now 
encompasses milestone reactions such as olefin metathesis,4.11 enyne metathesis4.12 and 
imine metathesis.4.13 Olefin metathesis reactions are very popular and useful reactions, 
which often occur under very mild conditions in the presence of an active catalytic 
species. The overall conversion of the reaction proceeds by a series of [2+2] 
cycloadditions and retrocycloadditions. There are three closely related types of olefin 
metathesis:4.14 ring opening metathesis polymerization (ROMP), ring closing metathesis 
(RCM) and exchange metathesis which may yield both self-metathesis and cross-














Scheme 4.1 Three General Metathesis Reactions 
complexes of Mo, W, Re, some Group 4 and 5 metals and Ru. Two very important 
ruthenium catalysts which show remarkable reactivity, selectivity and tolerance against 
various functional groups are the second generation Grubbs catalyst and the Hoveyda 
catalyst.4.15 The currently accepted mechanism4.16 was established by Chauvin and co-
workers and involves a cycloaddition reaction between a catalytic amount of metal 
carbene complex and an olefin to form a metallacyclobutane derivative. The four-
membered ring breaks apart in a retrocycloaddition to expel the new olefin and 
regenerate the metal carbene which continues the cycle (Scheme 4.2). 
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Scheme 4.2 Metathesis Mechanism 
4.4 Dimethyltitanocene [Cp2Ti=CH2] 
Dimethyltitanocene, a reasonably stable compound, first synthesized in 1956 by 
Clauss and Bestian, is readily prepared from methyllithium and titanocene dichloride 
(Cp2TiCl2). It has been extensively used as a reagent for stoichiometric transformations 
and more recently as a catalyst for some modern applications.4.17-18 The active species 
utilized for these reactions is the reactive titanium carbene complex [Cp2Ti=CH2]4.19 
formed via α−elimination of methane (Scheme 4.3).  
 
Scheme 4.3 Formation of Carbene Complex [Cp2Ti=CH2] 
Probably one of the most important applications of Cp2TiMe2 as a reagent is the 
methylenation of carbonyl compounds such as aldehydes, ketones, esters, etc, (Scheme 
4.4).4.17 The mechanism of the reaction involves a [2+2] cycloaddition between 
[Cp2Ti=CH2] and the carbonyl compound with a final loss of Cp2TiO (Scheme 4.5).  
R1 = Alkyl, Aryl
X = H, Alkyl, Aryl, OR', OSiR3, OCOR'





















Scheme 4.5 Methylenation of γ-Butyrolactone 
It is known that [Cp2Ti=CH2] is able to initiate the ring-opening metathesis 
polymerization (ROMP) of Norbornene (Scheme 4.6).4.18  
n
1.0 mol % Cp2TiMe2
70 oC, toulene  
Scheme 4.6 Cp2TiMe2-Catalyzed ROMP of Norbornene 
In combination with tungsten compounds (WOCl4, WCl6), Cp2TiMe2 further acts as a 




12 mol % Cp2TiMe2
+10 mol % WOCl4
70 oC, benzene
 
Scheme 4.7 Olefin Metathesis 
4.5 Research Interests  
As of yet, there are no reported results on metathesis products between imines and 
methylidenetitanocene. However, Group 4 carbene complexes are clearly known to react 
with a range of substrates, including imines, to give olefins. Schwartz and co-workers, 
discovered that not only does metathesis between zirconium carbene complexes and 
imines occur, but probed further into an existent correlation between the E/Z selectivity 
of the olefins formed and the size of the substituent group on the imine nitrogen (Scheme 
4.8).4.21 Also, we believe that imine metathesis with carbenes should be analogous to the 
methylenation reactions of carbonyl compounds.  
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Scheme 4.8 Zirconium Carbene Complex Metathesis 
Thus, based on these findings, we believe that the titanocene carbene complex 
[Cp2Ti=CH2], will likewise perform a [2+2] followed by a retro-[2+2] to form a 
catalytically active titanium-imido complex (Scheme 4.9).  
 
Scheme 4.9 Formation of an Titanium-imido Complex 
Although it is well known that [Cp2Ti=CH2] undergoes facile [2+2] cycloaddition with 
alkynes to yield titanacyclobutene intermediates (Scheme 4.10),4.22 we believe that the 
product azatitanocyclobutane formed from the carbene reacting with the imine would be 







R1 = R2 = Ethyl  
Scheme 4.10 Formation of Titanacyclobutenes 
The basis of this assumption is that the Ti-N bond formed is more stable than the Ti-C 
bond. The ring strain in the intermediate of these two reactions can, moreover, be 
accounted as one of the reasons for the preference of imine-carbene metathsis over 
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alkyne-carbene metathesis. The angle difference in titanacyclobutene is approximately 30 
degrees, where as in azatitanocyclobutane, its 19.5 degrees (Scheme 4.11).  
 
Scheme 4.11 Investigating Ti-N Bond Strength and Reduced Ring Strain 
Thus, the activation energy towards the formation of the titanacyclobutene is therefore, 
expected to be higher. 
Inspired by the work of Bergman et al.4.23 and Livinghouse et al.,4.24 work done by 
Doye and co-workers4.25 on the recently developed dimethytitanocene-catalyzed inter- 
and intra-molecular hydroamination of alkynes also represents another important 
application of Cp2TiMe2 as a catalyst (Scheme 4.12). 
 
Scheme 4.12 Cp2TiMe2-Catalyzed Intermolecular Hydroamination 
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It is assumed that Cp2TiMe2 reacts with an amine under loss of methane to form a 
catalytically active titanium-imido complex which undergoes a [2+2] cycloaddition with 
the alkyne. The resulting azatitanacyclobutene is then irreversibly protonated by further 
amine to form a titanocene bisamide, which is thermally cleaved into an enamine and the 
catalytically active titanium-imido complex. Finally, the enamine is converted into the 
imine under reaction conditions.  
With exactly the same intermediate at hand, we expect our titanium-imido 
complex to undergo an intramolecular [2+2] cycloaddition with the alkyne end on the 
substrate followed by a retro [2+2] to generate a carbene complex which could further 































Scheme 4.13 Postulated Imine-Alkyne Metathesis Mechanism 
 Alternatively, a possible imine insertion may occur into the titanium-vinyl 
bond of the azatitanacyclobutene. The corresponding 6-membered 
diazatitanacyclohexene derivative may then undergo subsequent retro [4+2] 
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cycloaddition to afford the desired product and regenerate the active titanium-imido 





















Scheme 4.14 Alternative Imine-Alkyne Insertion Mechanism 
Evidence for this proposed imine insertion mechanism comes from Doxsee et al.4.26 They 
previously reported unprecedented reactions of titanacyclobutenes, in which nitriles 
preferentially insert first into the titanium-vinyl bond of the titanacycle, then into the 
titanium-alkyl bond. They then, more recently reported that ketones and aldehydes 
undergo analogous preferential insertions into the titanium-vinyl bond of 
titanacyclobutenes (Scheme 4.15).  
 
Scheme 4.15 Evidence of Insertion Mechanism 
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This insertion is followed not by a second insertion, as observed for the nitrile reactions, 
but rather by facile thermal decomposition of the metallocyclic insertion product, 
apparently via a retro [4+2] reaction, to afford conjugated dienes in synthetically useful 
yields.  
As a result, we believe that existent literature, provides evidence which suggests 
that dimethyltitanocene may react with imino-alkynes via dual pathways depending on 
reaction conditions, one via the titanium carbene and one via an insertion mechanism. 
The scope of our study will involve investigating the behavior of the new catalytically 
active titanium-imido complexes and determining if the resulting conjugated azadiene 
species can further undergo a possible inverse electron demand aza-Diels-Alder reaction 

















Scheme 4.16 Performing Aza-Diels-Alder Reactions 
The second proposal is a novel, efficient synthetic route to pyrrolizidine alkaloids. 
Our research group recently reported the formal [2+2+1] cycloaddition of an alkene, a 
carbonyl and carbon monoxide towards the catalytic asymmetric carbonylation of γ-
butyrolactone ring skeleton (Scheme 4.17).4.27  
 
Scheme 4.17 Hetero-Pauson-Khand Reaction 
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This reaction is more commonly known as the Hetero-Pauson-Khand reaction.4.28 The 








M = Ti, Zr, Hf, Nb, Ta.....
A, B = C, N, O
Ln = ligand  
Scheme 4.18 Reductive Coupling 
Transition metal-mediated intramolecular reductive coupling refers to the coupling of a 
pair of  linked unsaturated organic bonds  to a metallacene with concomitant formation of 
a new carbon-carbon bond.4.29 The unsaturated organic fragments can be either alkenes, 
alkynes, carbonyls or imines. (Cp2Zr) and synthetic equivalents of Ti(II) are used 
frequently to affect reductive coupling and the Cp2M complexes formed are referred to as 
metallacycles.  
In 1996, Sato and co-workers reported a protocol for the synthesis of substituted 
pyrroles (Scheme 4.19).4.30 Hence, azatitanacyclopentenes formed by reductive coupling 
of δ-alkynyl imines using Ti(O-i-Pr)4/2 i-PrMgCl, could be carbonylated under standard 










n n nTi(O-i-Pr)4 CO
n = 1, 2
2 i-PrMgX
 
Scheme 4.19 Reductive Coupling of δ-Alkynyl Imines 
 204
In 1999, Murai and co-workers reported the Ru3(CO)12-catalyzed cyclocarbonylation of 





+        CO
cat. Ru3(CO)12
toulene











Scheme 4.20 Ru3(CO)12-Catalyzed Reaction of Yne-Imines 
incorporating the acetylenic π-bond, the imine π-bond and the carbon atom of CO. The 
product of these reactions is a γ-lactam. 
We, on the other hand, are interested in exploring this reaction with 
Cp2Ti(PMe3)2,4.32 a stable and isolable titanocene equivalent. We plan to coupling it with 
an imino-alkyne substrate, followed by carbonylation (Scheme 4.21). This route should 













Scheme 4.21 Proposed Synthesis of the Pyrrolizidine Moiety 
Thus, described in this study are the development of titanium-mediated reductive 
cyclocarbonylation and an imino-alkyne cross-metathesis strategy towards the synthesis 
of pyrrolizidine and indolizidine alkaloids respectively. The same substrates are 
employed for both reaction pathways. 
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4.6 Discussion 
 To obtain the imino-alkyne substrate we decided to first synthesize the 
aminoalkyne precursor and then react it with an appropriate aldehyde to form the desired 
imine bond. We first synthesized the aminoalkyne based on the technique known as the 
Ing-Mnske procedure (Method A).4.33 This method is a modification of the Gabriel 
synthesis in which the reaction of hydrazine with phthalimide or its N-substituted 













Scheme 4.22 Modified Gabriel Synthesis of Amines 
To obtain our target aminoalkyne, we began with commercially available 5-chloro-1-
pentyne, 4.1a. This was reacted with sodium iodide and potassium phthalimide 4.2a at 
100 °C in dimethylformide (DMF) (Scheme 4.23) to afford N-4-pentynylphthalimide 
4.3a quantitatively. 
Cl







4.1a 4.3a99%  
Scheme 4.23 Synthesis of Phthalamide 4.3a 
N-4-pentynylphthalimide 4.3a and hydrazine monohydrate were then allowed to react at  
60 °C, overnight, followed by addition of concentrated hydrochloric acid. After workup, 









30%4.3a 4.4a  
Scheme 4.24 Synthesis of Amine 4.4a (Method A) 
The low yield obtained by this method geared us into exploring one other possible route. 
This alternative route to obtaining 4-pentyn-1-amine 4.4a (Method B) was by an 
innovative method in which 4-pentyn-1-ol 4.3b was utilized as a key synthon and was 
converted into 4-pentyn-1-amine 4.4a using NaN3 and PPh3 in CCl4-DMF (1:4). 4.35 This 
reaction occurs in one step to yield the desired amine and a general scheme of this 




CCl4 - DMF (1:4)  
Scheme 4.25 Alternative Synthesis of Amines 
 4-pentyn-1-ol 4.3b can be derived from the inexpensive, commercially available 
tetrahydrofurfuryl alcohol 4.1b via the choride; tetrahydrofurfuryl chloride 4.2b (Scheme 
4.26). One of the most convenient methods for converting alcohols to chlorides is based 
on in situ generation of chlorophosphonium ions4.36 by reactions of triphenylphosphine 
with various chlorine compounds such as carbon tetrachloride.4.37 In order to obtain the 
chloride, 4.2b which will be converted into the amine 4.4a as described in the preceding 
paragraph, we decided to follow the procedure developed by Takano et al.4.38-39 In 
Takano’s paper, this route is applied to the construction of optically active 3-












Scheme 4.26 Takano’s Route 
 Starting from tetrahyrofurfuryl alcohol 4.1b, we applied the same set of 
conditions (Ph3P, 1.2 equiv.) for chlorination. Tetrahydrofurfuryl alcohol 4.1b and 
triphenylphosphine in excess carbon tetrachloride were refluxed for 4.5 h, during which 
time the chlorophosphonium ion reacted with the alcohol to give an alkoxyphosphonium 
ion, which was then converted to tetrahydrofurfuryl chloride 4.2b. Exposure of the 
chloride to butyllithium (3 equiv.) in tetrahydrofuran (THF) at -35 °C provided 4-pentyn-
1-ol 4.3b in 85% yield, presumably via a sequence triggered by initial generation of an α-





n-BuLi (3 equiv.) 
   THF, -35 oC
Ph3P (1.2 equiv.) 
    excess CCl4 




Scheme 4.27 Synthesis of Alcohol 4.3b 
As mentioned earlier, to obtain the aminoalkyne 4.4a, we followed the convenient and 
efficient one-pot sequence developed by Reddy et al.4.35 for the transformation of 






4.3b 4.4a90%  
Scheme 4.28 Synthesis of Amine 4.4a (Method B) 
Formation of the aminoalkyne may be visualized as the initial azide formed would react 
with the second equivalent of triphenylphosphine giving the iminophosphorane, which in 
turn converts into the aminoalkyne upon treatment with water (Scheme 4.29).  
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Scheme 4.29 Iminophosphorane Formation 
In summary, this alternative sequence of reactions provides an advantageous 
preparation of 4-pentyn-1-amine 4.4a over the Gabriel route based on higher yields and 
shorter number of steps. We next synthesized the desired imino-alkyne substrate 4.2c by 
a simple equimolecular condensation reaction4.41 between 4-pentyn-1-amine 4.4a and 
benzaldehyde 4.1c (Scheme 4.30). Anhydrous magnesium sulfate was successively added 









Scheme 4.30 Synthesis of Imine 4.2c 
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After the reaction was complete, the mixture was filtered, and the volatiles evaporated to 
obtain 4.2c as a bright yellow syrup (90% yield). Having our desired substrate at hand, 
we now focused on the proposed reactions. 
4.7 Results 
 Our cross-metathesis and cyclocarbonylation precursor 4.2c has been synthesized. 
We next undertook the titanium catalyzed/mediated cross-metathesis of 4.2c to produce 
the azadiene moiety.  
In order accomplish this, we synthesized the dimethyltitanocene reagent following 
a published literature procedure.4.42 Several reactions were carried out under a variety of 
reaction conditions, summarized in Table 4.1. 










Entry Reaction Condition Result 
1 20 mol % Cp2TiMe2, 60-65 oC, 48 h, Toluene  No Reaction 
2 20 mol % Cp2TiMe2, 110 oC, 48 h, Toluene No Reaction 
3 0.5 equiv. Cp2TiMe2, 110 oC, 48 h, Toluene No Reaction 
4 0.5 equiv. Cp2TiMe2, 60-65 oC, 48 h, THF No Reaction 
5 1.0 equiv. Cp2TiMe2, 110 oC, 48 h, THF No Reaction 
 
 Under the conditions described no titanium mediated cross metathesis was 
observed. The imino-alkyne starting material could be recovered.  
We also attempted the synthesis of the pyrrolizidine alkaloid skeleton 4.5c via 

















Scheme 4.31 Attempted Synthesis of Metallacycle 4.4c 
Cp2Ti(PMe3)2 was synthesized following a published literature procedure.4.43 The 
reaction conditions and results for the reductive coupling step is a follows in Table 4.2. 
Table 4.2 Attempted Reductive Coupling Conditions for Imine 4.2c 
Entry Reaction Conditions Results 
1 1.0 equiv. Cp2Ti(PMe3)2, rt, 2 h, Pentane Green Oil, Decomposition 
2 1.0 equiv. Cp2Ti(PMe3)2, rt, 2 h, Ether Green Oil, Decomposition 
 
The first reductive cyclization reaction was run with a stiochiometric amount of 
Cp2Ti(PMe3)2 utilizing pentane as the reaction solvent. This resulted in a green color in 
the reaction and subsequently a green oil which simply showed decomposition of both 
reagent and 4.2c via NMR. The next solvent tried was diethyl ether. Identical 
observations were made. Work done by Negishi4.44 has shown that terminal acetylenes 
undergo reductive cyclizations very poorly or not at all presumably due to the reaction of 
the acidic acetylenic hydrogen with the basic metallacene. In concluding, a different 
strategy will have to be invented for the synthesis of such interesting alkaloids and will 
be the topic of future accounts from this laboratory. 
4.8 Experimental Section 
4.8.1 General Methods 
 All the experiments were performed under a nitrogen or argon atmosphere in oven 
dried glassware. Solvents used as reaction media were distilled immediately before use. 
Diethyl ether, THF, pentane, and toluene were distilled from Na/benzophenone ketyl. 
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Methylene chloride was distilled from calcium hydride. Other reagents were purified by 
simple distillation or passed through a short column of activated alumina or silica gel. 
 1H spectra and 13C NMR spectra were recorded on a Bruker 250 MHz 
spectrometer in deuterated chloroform (CHCl3: 7.27 ppm 1H, 77.23 ppm 13C). Chemical 
shifts (δ) are given in parts per million down from tetramethylsilane (TMS); multiplicities 
are indicated as br (broadened), s (singlet), t (triplet), q, quintet, td (triplet of doublets), m 
(multiplet), coupling constant (Hz), and intergration. 
 Analytical TLC was performed on Scientific Adsorbent Company Inc. silica gel 
plates. Components were visualized by illumination with long wave ultraviolet light, 
exposure to iodine vapor, or by standing with p-anisaldehyde in ethanol/sulfuric acid. 
Flash column chromatography was performed using silica gel (Scientific Adsorbent 
Company Inc. 32-63 μm particle size, 60 Å pore size). 
4.8.2 Preparative Procedures 
Cl







4.1a 4.3a99%  
N-4-Pentynylphthalimide (4.3a). A suspension of 5-chloro-1-pentyne 4.1a (2.5 g, 24 
mmol), potassium phthalimide (5.4 g, 29 mmol), and NaI (15.3 mg) in DMF (16 mL) was 
refluxed, with stirring, under inert atmosphere, at 100 °C overnight. The solution was 
allowed to warm to room temperature and treated with water (16 mL). N-4-
entynylphthalimide 4.3a crystals immediately precipitated. The product was then washed 
with copious amounts of water to remove any residual DMF. The pure yellow crystals 
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(5.16 g) were then dried under high vacuum and used in the next step without further 
purification. Yield (99 %). 1H NMR (250 MHz, CDCl3): δ 7.84-7.81 (m, 2H), 7.71-7.68 
(m, 2H), 3.78 (t, J = 6.6 Hz, 2H), 2.27-2.23 (m, 2H), 1.94-1.85 (m, 3H); 13C NMR (62.5 








30%4.3a 4.4a  
4-pentyn-1-amine (4.4a) (Method A). N-4-pentynylphthalimide 4.3a (4.0 g, 19.0  
mmol) and hydrazine monohydrate (2.557 g, 51.0 mmol) in MeOH (170 mL) were heated 
with stirring at 60 °C overnight. After the mixture was cooled to room temperature, 
followed by the addition of concentrated HCl, (3.5 mL) the solution was heated at 60 °C 
for an additional 4 h. The mixture was then cooled and filtered, and the white precipitate 
washed with EtOH (50 mL). Removal of solvent from the combined filtrates at reduced 
pressure gave a white precipitate. The white solid was then treated with a mixture of 
KOH (2N, 18 mL) and diethyl ether (15 mL). After separation, the organic phase was 
extracted with diethyl ether (3x10 mL). The ether phase was then washed with brine (5 
mL) and dried over Na2SO4. After filtration and removal of solvent from the filtrate by 
rotary evaporation, distillation (124-125 °C) afforded 4-pentyn-1-amine (0.466 g). Yield 
(30%). 1H NMR (250 MHz, CDCl3): δ 2.62 (t, J = 13.7 Hz, 2H), 2.09 (td, J = 7.0 Hz, J = 
2.6 Hz, 2H), 1.82 (t, J = 2.6 Hz, 1H), 1.51-1.42 (m, 2H), 1.40 (br s, 2H); 13C NMR (62.5 






Ph3P (1.2 equiv.) 
    excess CCl4 




Tetrahydrofurfuryl chloride (4.2b). A solution of tetrahydrofurfuryl alcohol (13 g, 127 
mmol) and triphenylphosphine (40 g, 150 mmol) in CCl4 (115 mL) was refluxed for 4 h. 
After the solution was cooled to room temperature, Et2O (60 mL) was added to the 
mixture, and the solid that separated was removed by filtration. The filtrate was 
concentrated to give an oil (11.5 g), which was used without further purification. Yield 
(75%). 1H NMR (250 MHz, CDCl3): δ 4.17-4.12 (m, 1H), 3.94-3.83 (m, 2H), 3.58-3.52 
(m, 2H), 2.09-1.92 (m, 3H), 1.80-1.70 (m, 1H); 13C NMR (62.5 MHz, CDCl3): δ 78.7, 
69.1, 47.2, 29.6, 26.1.  
O
Cl HO
n-BuLi (3 equiv.) 




4-pentyn-1-ol (4.3b). To a -35 °C, stirred solution of tetrahydrofurfuryl chloride (2.48 g, 
21 mmol) in THF (23 mL) was added drop-wise BuLi (37.2 mL in a 1.66 M solution in 
hexane, 62 mmol) under N2. The mixture was stirred at the same temperature for 4 h, 
quenched with water (20 mL), and extracted with Et2O (20 mL). The extracts were 
washed with brine (15 mL), dried (MgSO4), and concentrated. Column chromatography 
(silica gel, hexanes/Et2O, 2:1) yielded the purified residual oil. Yield (85%). 1H NMR 
(250 MHz, CDCl3): δ 3.58 (m, 2H), 2.17 (m, 2H), 1.89 (t, J = 2.6 Hz, 1H), 1.64 (q, J = 







4.3b 4.4a90%  
4-pentyn-1-amine (4.4a) (Method B). A mixture of alcohol (0.73 g, 0.868  mmol), 
sodium azide (0.68 g, 10 mmol) and triphenylphosphine (4.78 g, 18 mmol) in CCl4-DMF 
(1:4) (44 mL) was warmed at 90 °C with stirring. After total disappearance of starting 
material (monitored by TLC: 2:1 (Hexane: Et2O)), reaction mixture was brought to room 
temperature and quenched by adding water (21 mL). After stirring for 10 min, the 
reaction mixture was diluted with ether (30 mL) and washed thoroughly with water. By 
tituration of the ether fraction at 0 °C, triphenylphosphine oxide was crystallized out and 
ether was filtered off.  After drying over anhydrous Na2SO4, filtration and concentration 
of solvent afforded the amine in pure form (0.58 g) as a yellow liquid. Yield (90%). 1H 
NMR (250 MHz, CDCl3): δ 2.62 (t, J = 13.7 Hz, 2H), 2.09 (td, J = 7.0 Hz, J = 2.6 Hz, 
2H), 1.82 (t, J = 2.6 Hz, 1H), 1.51-1.42 (m, 2H), 1.40 (br s, 2H); 13C NMR (62.5 MHz, 









Imino-Alkyne substrate (4.2c). 4-pentyn-1-amine 4.4a (1.00 g, 12 mmol) and 
benzaldehyde 4.1c (1.28 g, 12 mmol) were allowed to react overnight in methylene 
chloride (30 mL) at room temperature in the presence of anhydrous MgSO4 (3.0 g). After 
filtration, the solvent was removed and the product isolated in pure form (1.85 g). Yield 
(90%). 1H NMR (250 MHz, CDCl3): δ 8.30 (s, 1H), 7.75-7.72 (m, 2H), 7.41-7.39 (m, 
 215
3H), 3.74-3.69 (m, 2H), 2.32-2.25 (m, 2H), 2.00-1.91 (m, 3H); 13C NMR (62.5 MHz, 
CDCl3): δ 161.9, 136.6, 131.0, 129.0, 128.5, 84.3, 69.2. 60.2, 29.8, 16.5. 
4.8.3 Spectral Data 
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